Peter Malfertheiner

Peter Malfertheiner's AcademicInfluence.com Rankings

Peter Malfertheiner

Philosophy

#2796

World Rank

#4666

Historical Rank

Logic

#787

World Rank

#1322

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Peter Malfertheiner Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter Malfertheiner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report (2006) (2333)
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report (2012) (2271)
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report (2016) (2261)
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. (2017) (1653)
Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report (2002) (1309)
Kyoto global consensus report on Helicobacter pylori gastritis (2015) (1167)
Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). (1997) (898)
European consensus conference on faecal microbiota transplantation in clinical practice (2017) (705)
Peptic ulcer disease (2002) (673)
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) (2011) (533)
Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. (2004) (476)
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer (2010) (456)
Hepatocellular Carcinoma – Epidemiological Trends and Risk Factors (2009) (453)
Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. (2011) (446)
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial (2011) (425)
Analysis of nerves in chronic pancreatitis. (1988) (390)
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. (2012) (383)
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) (2012) (374)
Diagnosis of Helicobacter pylori infection with a new non-in vasive antigen-based assay (1999) (344)
Hepatocellular carcinoma (HCC): a global perspective. (2010) (325)
OLGA staging for gastritis: a tutorial. (2008) (300)
European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection. The Maasticht 2-2000 Consensus Report (2002) (290)
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. (2011) (287)
Human pancreatic tissue concentration of bactericidal antibiotics. (1992) (277)
Prevalence of extra‐oesophageal manifestations in gastro‐oesophageal reflux disease: an analysis based on the ProGERD Study (2003) (257)
Quality of life in relation to symptoms in patients with gastro‐oesophageal reflux disease — an analysis based on the ProGERD initiative (2003) (256)
Oxidative stress in ulcerative colitis-associated carcinogenesis. (2008) (253)
The role of infection in acute pancreatitis (1999) (250)
Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique (2005) (244)
The coccoid forms of Helicobacter pylori. Criteria for their viability (1993) (243)
The stomach in health and disease (2015) (239)
Fecal elastase test: evaluation of a new noninvasive pancreatic function test. (1995) (219)
Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. (1999) (213)
Inhibition of p38 MAP kinase‐and RICK/NF‐κB‐signaling suppresses inflammatory bowel disease (2004) (210)
The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany (2000) (205)
PMN‐Elastase in Comparison with CRP, Antiproteases, and LDH as Indicators of Necrosis in Human Acute Pancreatitis (1991) (202)
A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis (1999) (195)
Risk Factors for Erosive Esophagitis: A Multivariate Analysis Based on the ProGERD Study Initiative (2004) (194)
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma. (2019) (191)
EUS in the diagnosis of early chronic pancreatitis: a prospective follow-up study. (2002) (189)
A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. (1997) (187)
World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. (2010) (182)
Identification of pancreas necrosis in severe acute pancreatitis: imaging procedures versus clinical staging. (1986) (181)
Diagnostic and therapeutic impact of double-balloon enteroscopy. (2006) (180)
The 5300-year-old Helicobacter pylori genome of the Iceman (2016) (177)
Changes in Peptidergic Innervation in Chronic Pancreatitis (1992) (176)
Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study. (2008) (176)
STW 5, a Phytopharmacon for Patients With Functional Dyspepsia: Results of a Multicenter, Placebo-Controlled Double-Blind Study (2007) (175)
Symptoms and Quality of Life in Chronic Pancreatitis Assessed by Structured Interview and the EORTC QLQ-C30 and QLQ-PAN26 (2005) (173)
World Gastroenterology Organisation global guideline: Constipation--a global perspective. (2011) (169)
Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers (2012) (165)
Prospective Follow-Up Data from the ProGERD Study Suggest that GERD Is Not a Categorial Disease (2006) (164)
Proton-pump inhibitors: understanding the complications and risks (2017) (163)
Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics. (2019) (162)
A meta‐analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori‐associated gastric or duodenal ulcer (2001) (160)
BOB CAT: a Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia (2015) (158)
Helicobacter pylori in developing countries (2010) (158)
Pathogenetic implications of ultrastructural findings in Campylobacter pylori related gastroduodenal disease. (1988) (155)
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus (2020) (154)
Gastric Cancer as Preventable Disease (2017) (153)
Inhibition of RICK/Nuclear Factor-κB and p38 Signaling Attenuates the Inflammatory Response in a Murine Model of Crohn Disease* (2005) (152)
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. (1999) (152)
Intestinal metaplasia at the gastro-oesophageal junction:Helicobacter pylori gastritis or gastro-oesophageal reflux disease? (1998) (151)
Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? (1997) (150)
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. (2004) (149)
Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo (2006) (148)
Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. (1998) (145)
Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. (1991) (144)
Gabexate mesilate in human acute pancreatitis (1993) (143)
Meta-Analysis of Bismuth Quadruple Therapy versus Clarithromycin Triple Therapy for Empiric Primary Treatment of Helicobacter pylori Infection (2013) (142)
Helicobacter pylori and molecular events in precancerous gastric lesions (2004) (142)
Helicobacter pylori infection: a clinical overview. (2008) (142)
Evolution of gastro‐oesophageal reflux disease over 5 years under routine medical care – the ProGERD study (2012) (141)
Helicobacter pylori: perspectives and time trends (2014) (140)
Diagnosis and Management of Non-Erosive Reflux Disease – The Vevey NERD Consensus Group (2009) (139)
Increased β-catenin mRNA levels and mutational alterations of the APC and β-catenin gene are present in intestinal-type gastric cancer (2002) (138)
Management of severe acute pancreatitis. (1993) (138)
Gastric cancer: epidemiology, prevention, and therapy (2018) (138)
The active bacterial assemblages of the upper GI tract in individuals with and without Helicobacter infection (2016) (137)
Pancreatic Necrosis: An Early Finding in Severe Acute Pancreatitis (1993) (136)
Role of phospholipase A2 in human acute pancreatitis. (1989) (134)
Risk factors for failure of endoscopic stenting of biliary strictures in chronic pancreatitis: a prospective follow-up study (2003) (133)
A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia. (2008) (129)
Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. (2004) (128)
The GU‐MACH study: the effect of 1‐week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer (1999) (127)
Maldigestion after total gastrectomy is associated with pancreatic insufficiency. (1996) (121)
Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas. (2006) (119)
Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study (2000) (119)
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report (2022) (115)
Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn. (2015) (115)
Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis. (2008) (115)
Incidence of bleeding lesions within reach of conventional upper and lower endoscopes in patients undergoing double‐balloon enteroscopy for obscure gastrointestinal bleeding (2009) (113)
New algorithm for the treatment of gastro‐oesophageal reflux disease (2007) (112)
Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival. (2010) (111)
Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. (1998) (110)
L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial (2012) (109)
Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non‐neoplastic gastric tissues (2002) (108)
Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. (1997) (106)
Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. (2002) (104)
Helicobacter pylori research: historical insights and future directions (2013) (104)
Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting (1999) (103)
Overexpression of cathepsin B in gastric cancer identified by proteome analysis (2005) (103)
A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis (2010) (103)
Prognostic influence of Barrett’s oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study (2005) (102)
Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. (1993) (102)
Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events (2016) (101)
Loss of beta-catenin expression in metastatic gastric cancer. (2003) (101)
Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver (2014) (99)
Therapeutic ERCP with the double-balloon enteroscope in patients with Roux-en-Y anastomosis. (2008) (99)
A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis. (2007) (98)
Association of body mass index with heartburn, regurgitation and esophagitis: Results of the Progression of Gastroesophageal Reflux Disease study (2007) (98)
Up‐regulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer (2005) (97)
High rate of post‐therapeutic resistance after failure of macrolide–nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second‐line therapies in a randomized study (2002) (96)
Macro-Role of MicroRNA in Gastric Cancer (2012) (95)
Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori (2014) (93)
The Number of Lymph Node Metastases in Gastric Cancer Correlates with the Angiotensin I–Converting Enzyme Gene Insertion/Deletion Polymorphism (2005) (93)
Naturally Occurring Regulatory T cells (CD4+, CD25high, FOXP3+) in the Antrum and Cardia are Associated with Higher H. pylori Colonization and Increased Gene Expression of TGF‐β1 (2008) (92)
ERCP with the double balloon enteroscope in patients with Roux-en-Y anastomosis (2009) (91)
Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC). (2015) (91)
Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease — results from a randomized trial programme (2002) (91)
STW 5 (Iberogast®)—a safe and effective standard in the treatment of functional gastrointestinal disorders (2012) (91)
Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry. (2006) (90)
Gastric cancer – clinical and epidemiological aspects (2016) (88)
Identification of gastric cancer patients by serum protein profiling. (2004) (87)
Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. (1995) (87)
Correlation of imaging and function in chronic pancreatitis. (1989) (87)
Endoscopic Retrograde Cholangiopancreatography Using the Single Balloon Enteroscope Technique in Patients with Roux-en-Y Anastomosis (2009) (87)
Echo enhanced ultrasound: a new valid initial imaging approach for severe acute pancreatitis (2005) (86)
Expression of carbonic anhydrase 9 at the invasion front of gastric cancers (2005) (85)
Development of vaccines against Helicobacter pylori (2009) (85)
Markers for predicting severity and progression of acute pancreatitis. (2008) (85)
Analysis of Transcriptionally Active Bacteria Throughout the Gastrointestinal Tract of Healthy Individuals. (2019) (85)
The Intriguing Relationship of Helicobacter pylori Infection and Acid Secretion in Peptic Ulcer Disease and Gastric Cancer (2011) (84)
Hepatic Toxicity After Radioembolization of the Liver Using 90Y-Microspheres: Sequential Lobar Versus Whole Liver Approach (2012) (84)
Nutrition in Patients with Gastric Cancer: An Update (2016) (84)
Smoking—A Trigger for Chronic Inflammation and Cancer Development in the Pancreas (2006) (83)
Clinical manifestations and complications of gastroesophageal reflux disease (GERD) (2005) (83)
H. pylori Infection Is a Key Risk Factor for Proximal Gastric Cancer (2010) (83)
Serological assessment of gastric mucosal atrophy in gastric cancer (2012) (83)
A proposal for a new clinical classification of chronic pancreatitis (2009) (82)
Technical annex: tests used to assess Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. (1997) (82)
Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia (2003) (82)
Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis. (2015) (81)
Is increased pancreatic pressure related to pain in chronic pancreatitis? (1994) (80)
Identification of Enterohepatic Helicobacter Species in Patients Suffering from Inflammatory Bowel Disease (2004) (80)
Growth Inhibitory and Bactericidal Activities of Lansoprazole Compared with Those of Omeprazole and Pantoprazole against Helicobacter pylori (1998) (80)
Standards in Pancreatic Surgery (1993) (80)
Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases. (2018) (80)
Influence of Contrast-enhanced Computed Tomography on Course and Outcome in Patients with Acute Pancreatitis (2002) (79)
Detection of Neuroendocrine Tumors of the Small Bowel by Double Balloon Enteroscopy (2009) (79)
Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC (2015) (78)
Advances, challenges, and limitations in serum-proteome-based cancer diagnosis. (2006) (78)
Influence of anti‐Helicobacter triple‐therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora (2001) (78)
A retrospective analysis of emergency double-balloon enteroscopy for small-bowel bleeding. (2009) (78)
Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score (2017) (78)
Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. (1993) (78)
Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins. (2004) (77)
Coccoid like forms (CLF) of Helicobacter pylori. Enzyme activity and antigenicity. (1993) (77)
Gastrointestinal motility in patients with non-ulcer dyspepsia: a role for Helicobacter pylori infection? (1993) (77)
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro‐oesophageal reflux disease (2011) (77)
Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps (2019) (76)
OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long‐term Follow‐up Study of 7436 Patients (2018) (76)
Antibiotic susceptibility of Helicobacter pylori in central Germany and its relationship with the number of eradication therapies (2013) (76)
Budesonide induces complete remission in autoimmune hepatitis. (2006) (76)
Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. (2002) (76)
Impact of Furazolidone‐Based Quadruple Therapy for Eradication of Helicobacter pylori after Previous Treatment Failures (2002) (76)
Helicobacter pylori and nonmalignant diseases (2002) (76)
Duodenum-preserving pancreatic head resection: long-term results (2006) (75)
[S3-guideline "Helicobacter pylori and gastroduodenal ulcer disease"]. (2009) (74)
Helicobacter pylori, Gastritis and Peptic Ulcer (2011) (73)
Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1 (2002) (73)
Hyperlipidemia in acute pancreatitis (1995) (72)
ERCP using single-balloon instead of double-balloon enteroscopy in patients with Roux-en-Y anastomosis. (2008) (72)
Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers. (2005) (72)
Exocrine pancreatic function in correlation to ductal and parenchymal morphology in chronic pancreatitis. (1986) (72)
S3-guideline "helicobacter pylori and gastroduodenal ulcer disease" of the German society for digestive and metabolic diseases (DGVS) in cooperation with the German society for hygiene and microbiology, society for pediatric gastroenterology and nutrition e. V., German society for rheumatology, AWMF (2009) (71)
Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis. (2005) (71)
Human Cathepsin W, a Cysteine Protease Predominantly Expressed in NK Cells, Is Mainly Localized in the Endoplasmic Reticulum1 (2001) (71)
Gene Polymorphisms of Micrornas in Helicobacter pylori-Induced High Risk Atrophic Gastritis and Gastric Cancer (2014) (70)
Feasibility of Fecal MicroRNAs as Novel Biomarkers for Pancreatic Cancer (2012) (70)
Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease. (2011) (70)
Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infection. (2014) (70)
Histomorphological differentiation of non‐erosive reflux disease and functional heartburn in patients with PPI‐refractory heartburn (2013) (70)
Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians (2011) (70)
World gastroenterology organisation global guidelines: dysphagia--global guidelines and cascades update September 2014. (2015) (69)
Escherichia coli Nissle 1917 (Mutaflor): New Insights into an Old Probiotic Bacterium (2011) (68)
COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist (2020) (67)
An approach to Helicobacter pylori infection in the elderly (2002) (67)
Treatment of uncomplicated reflux disease. (2005) (67)
Feasibility of double-balloon enteroscopy-assisted chromoendoscopy of the small bowel in patients with familial adenomatous polyposis. (2007) (66)
Tumor‐associated autoantibody signature for the early detection of gastric cancer (2013) (66)
International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus (2015) (66)
Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer (2011) (65)
Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study. (1999) (65)
Advanced colon polypectomy. (2009) (65)
Modern diagnostics of chronic pancreatitis (2002) (65)
Endoscopic Ultrasound in Pancreatic Diseases (2003) (64)
Gastric Cancer: Clinical Aspects, Epidemiology and Molecular Background (2011) (64)
Procaine Hydrochloride Fails to Relieve Pain in Patients with Acute Pancreatitis (2004) (64)
Identification of structures containing polyphosphate in Helicobacter pylori. (1993) (64)
Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density (2001) (63)
Helicobacter pylori but not gastrin is associated with the development of colonic neoplasms (2014) (63)
Prevalence and pattern of Helicobacter pylori gastritis in the gastric cardia. (1997) (63)
Molecular markers of pancreatic cancer: development and clinical relevance (2008) (62)
Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis (2016) (62)
The prevalence of gastric heterotopia of the proximal esophagus is underestimated, but preneoplasia is rare - correlation with Barrett’s esophagus (2017) (62)
The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia (2005) (62)
Proteinase-Activated Receptor-2 in the Pathogenesis of Gastroesophageal Reflux Disease (2010) (62)
Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: a Network Meta-Analysis. (2021) (61)
Follow-Up After Acute Pancreatitis: Morphology and Function (1987) (61)
Epigenetic silencing of miR‐137 is a frequent event in gastric carcinogenesis (2016) (61)
Gastroesophageal reflux disease—from reflux episodes to mucosal inflammation (2012) (61)
A metastatic endocrine-neurogenic tumor of the ampulla of Vater with multiple endocrine immunoreaction--malignant paraganglioma? (1985) (61)
Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment (2016) (61)
Inflammation and Barrett's carcinogenesis. (2012) (61)
Serological Prevalence of Helicobacter pylori Infection in Saxony-Anhalt, Germany, in 2010 (2011) (61)
What Parameters Are Relevant for the Histological Diagnosis of Gastroesophageal Reflux Disease without Barrett’s Mucosa? (2004) (60)
Does the treatment of gastroesophageal reflux disease (GERD) meet patients’ needs? A survey‐based study (2006) (60)
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study. (2017) (60)
Drug treatment of functional dyspepsia. (2006) (60)
Long-Term Results with a New Introducer Method with Gastropexy for Percutaneous Endoscopic Gastrostomy (2006) (59)
European multicentre validation trial of two new non‐invasive tests for the detection of Helicobacter pylori antibodies: urine‐based ELISA and rapid urine test (2003) (59)
Dyspepsia and IBS Symptoms in Patients with NERD, ERD and Barrett’s Esophagus (2008) (59)
Helicobacter pylori, gastric cancer and other gastrointestinal malignancies (2017) (59)
Increased expression of survivin in gastric cancer patients and in first degree relatives (2002) (58)
Impact of the operator's experience on value of high-resolution transabdominal ultrasound in the diagnosis of choledocholithiasis: A prospective comparison using endoscopic retrograde cholangiography as the gold standard (2006) (58)
Small bowel polyps and tumours: endoscopic detection and treatment by double‐balloon enteroscopy (2009) (58)
Demonstration of a phospholipid-rich zone in the human gastric epithelium damaged by Helicobacter pylori. (1993) (57)
A gradient of TFF3 (trefoil factor family 3) peptide synthesis within the normal human gastric mucosa (2004) (57)
New strategies for Helicobacter pylori eradication. (2008) (56)
Prevalence of and risk factors for Helicobacter pylori infection in the western part of Germany (1996) (56)
Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer (2000) (56)
Contrast-enhanced ultrasound in the diagnosis of pancreatic tumors. (2006) (56)
The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: a case‐control study (1998) (55)
Sorafenib in Patients with Hepatocellular Carcinoma—Results of the Observational INSIGHT Study (2017) (55)
Helicobacter pylori: clinical management (2012) (55)
Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas. (2008) (55)
Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux disease (2003) (54)
Does cure of Helicobacter pylori infection induce heartburn (1998) (54)
Helicobacter pylori and gastroduodenal ulcer disease. (2009) (54)
Lansoprazole Fast Disintegrating Tablet: A New Formulation for an Established Proton Pump Inhibitor (2003) (54)
Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach. (2005) (54)
Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn’s disease (2012) (54)
The Angiotensin I–Converting Enzyme Gene Insertion/Deletion Polymorphism Is Linked to Early Gastric Cancer (2005) (53)
A novel immunoassay based on monoclonal antibodies for the detection of Helicobacter pylori antigens in human stool. (2001) (53)
A Group‐Specific PCR Assay for the Detection of Helicobacteraceae in Human Gut (2002) (53)
Effect of Helicobacter pylori eradication on expression of cyclin D2 and p27 in gastric intestinal metaplasia (2001) (53)
Expression of carbonic anhydrase IX in human pancreatic cancer (2003) (53)
Jackhammer esophagus: high-resolution manometry and therapeutic approach using peroral endoscopic myotomy (POEM). (2016) (53)
Missing gastric cancer in dyspepsia (2005) (53)
Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett's esophagus: an entity of concern in the ProGERD study (2012) (52)
APC promoter methylation and protein expression in hepatocellular carcinoma (2007) (52)
Chronic gastritis - an update. (2014) (51)
Helicobacter pylori and non‐malignant upper gastrointestinal diseases (2016) (51)
Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors. (1993) (51)
Large-needle biopsy versus thin-needle biopsy in diagnostic pathology of liver diseases. (2001) (51)
Modified rapid urease test for detection of Helicobacter pylori infection (1996) (51)
Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression. (2007) (51)
Histological diagnosis of Helicobacter pylori gastritis is predictive of a high risk of gastric carcinoma (1997) (51)
Double-balloon enteroscopy-assisted virtual chromoendoscopy for small-bowel disorders: a case series. (2009) (51)
Fluorescein Dilaurate Serum Test: A Rapid Tubeless Pancreatic Function Test (1987) (50)
Validation of the Reflux Disease Questionnaire for a German population (2005) (50)
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). (2001) (50)
Efficacy, Complications and Clinical Outcomes of Endoscopic Sclerotherapy with N-Butyl-2-Cyanoacrylate for Bleeding Gastric Varices (2009) (50)
Current Standards in the Diagnosis of Helicobacter pylori Infection (2001) (50)
Role of regulatory T-cells in H. pylori-induced gastritis and gastric cancer. (2010) (50)
Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study. (2018) (50)
Helicobacter pylori: diagnosis and treatment (2009) (49)
Helicobacter pylori Encoding the Pathogenicity Island Activates Matrix Metalloproteinase 1 in Gastric Epithelial Cells via JNK and ERK* (2006) (49)
Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid. (2005) (49)
S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit (2016) (49)
Helicobacter pylori infection and current clinical areas of contention (2010) (49)
Hyperlipidemia in acute pancreatitis. Cause or epiphenomenon? (1995) (48)
The role of the gastric bacterial microbiome in gastric cancer: Helicobacter pylori and beyond (2019) (48)
Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome (2016) (48)
Helicobacter pylori enzymes. (1996) (48)
Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer (2015) (47)
Interleukin-1Beta and Interleukin-8 Expression Correlate with the Histomorphological Changes in Esophageal Mucosa of Patients with Erosive and Non-Erosive Reflux Disease (2009) (47)
The role of viral and bacterial pathogens in gastrointestinal cancer (2008) (47)
Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma (2010) (47)
Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. (2000) (47)
Prevalence and Spread of Enterohepatic Helicobacter Species in Mice Reared in a Specific-Pathogen-Free Animal Facility (2006) (47)
Helicobacter pylori Treatment for Gastric Cancer Prevention. (2018) (46)
Review: Gastric cancer—Clinical aspects (2019) (46)
Cathepsins K, L, B, X and W are differentially expressed in normal and chronically inflamed gastric mucosa (2004) (46)
Autoimmune gastritis in autoimmune thyroid disease (2015) (46)
Gastric emptying of solids and liquids in obesity (1993) (46)
A prospective longitudinal cohort study: evolution of GERD symptoms during the course of pregnancy (2012) (46)
Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer. (2007) (46)
Free fatty acids in serum of patients with acute necrotizing or edematous pancreatitis (1993) (45)
Multicenter evaluation of a specific pancreatic isoamylase assay based on a double monoclonal-antibody technique. (1988) (45)
Treatment of Benign Biliary Strictures in Chronic Pancreatitis by Self-Expandable Metal Stents (2003) (45)
Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials (2016) (45)
Helicobacter and Gastric Malignancies (2007) (44)
Differing patterns of Helicobacter pylori gastritis in patients with duodenal, prepyloric, and gastric ulcer disease. (1998) (44)
Interdigestive cycling in chronic pancreatitis: altered coordination among pancreatic secretion, motility, and hormones. (1995) (44)
From Gastric Inflammation to Gastric Cancer (2010) (43)
Cure of Helicobacter pylori-associated ulcer disease through eradication. (2000) (43)
HER2 status in gastroesophageal cancer: a tissue microarray study of 1040 cases. (2015) (43)
The placebo response in functional dyspepsia – reanalysis of trial data (2009) (43)
Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany. (2003) (43)
Helicobacter pylori and Other Gastric Microbiota in Gastroduodenal Pathologies (2016) (43)
Exocrine pancreatic function in the early phase of human acute pancreatitis. (1995) (43)
Feasibility of histological grading and staging of chronic viral hepatitis using specimens obtained by thin-needle biopsy (2003) (43)
Delayed Diagnosis of HCC with Chronic Alcoholic Liver Disease (2012) (43)
[S2k-guideline gastrointestinal infectious diseases and Whipple's disease]. (2015) (42)
Differential Expression of Human Beta Defensin 2 and 3 in Gastric Mucosa of Helicobacter pylori‐Infected Individuals (2013) (42)
Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: evidence from clinical and pharmacokinetic data. (2005) (42)
Infection: Bismuth improves PPI-based triple therapy for H. pylori eradication (2010) (42)
Role of tight junction proteins in gastroesophageal reflux disease (2012) (41)
Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer (2003) (41)
Octreotide LAR: safety and tolerability issues (2009) (41)
Alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first-degree relatives (2000) (41)
Treatment of Helicobacter pylori (2011) (41)
Fusobacterium nucleatum is associated with worse prognosis in Lauren’s diffuse type gastric cancer patients (2020) (41)
Usefulness of the double-balloon enteroscope in colonoscopies performed in patients with previously failed colonoscopy (2007) (41)
World Gastroenterology Organisation Global Guidelines Helicobacter pylori in developing countries August 2010 : WGO global guidelines (2011) (41)
Role of Endoscopic Ultrasound in the Diagnosis of Patients with Solid Pancreatic Masses (2004) (40)
Differential expression of microRNAs in preneoplastic gastric mucosa (2015) (40)
Influence of Cyclooxygenase Inhibitors on the Function of the Prostaglandin Transporter Organic Anion-Transporting Polypeptide 2A1 Expressed in Human Gastroduodenal Mucosa (2010) (40)
Cost‐of‐disease analysis in patients with gastro‐oesophageal reflux disease and Barrett's mucosa (2006) (40)
Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial (2019) (40)
Pathogenesis of sporadic and familial gastric cancer – implications for clinical management and cancer prevention (2002) (39)
Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract—evidence from next‐generation sequencing studies (2020) (39)
Low prevalence of Helicobacteraceae in gall-stone disease and gall-bladder carcinoma in the German population. (2007) (39)
Can gastric cancer be prevented by Helicobacter pylori eradication? (2006) (39)
Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma. (2010) (39)
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. (2006) (38)
Interdigestive gastroduodenal motility and cycling of putative regulatory hormones in severe obesity. (1992) (38)
Induction of TFF1 gene expression in pancreas overexpressing transforming growth factor α (1999) (38)
The impact of combining Selective Internal Radiation Therapy (SIRT) with Sorafenib on overall survival in patients with advanced hepatocellular carcinoma: The Soramic trial palliative cohort (2018) (38)
The tyrosine kinase inhibitor imatinib fails to inhibit pancreatic cancer progression. (2006) (38)
Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication (2009) (38)
[Value of biochemical and imaging procedures for the diagnosis and prognosis of acute pancreatitis--results of a prospective clinical study]. (1986) (37)
Systematic review: endoluminal therapy for gastro-oesophageal reflux disease: evidence from clinical trials. (2007) (37)
Comparison of two enzyme immunoassays for the assessment of Helicobacter pylori status in stool specimens after eradication therapy (2002) (37)
Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients (2008) (36)
Antigen stool test for assessment of Helicobacter pylori infection in patients with upper gastrointestinal bleeding (2003) (36)
Effect of Pancreatic Ductal and Parenchymal Changes on Exocrine Function in Chronic Pancreatitis (1995) (36)
A Two-Step Method for the Extraction of High-Quality RNA from Endoscopic Biopsies (2003) (36)
Elan study proves symptomatic benefit of Helicobacter pylori eradication in functional dyspepsia(FD) (2000) (36)
Reduced PTEN expression in gastric cancer and in the gastric mucosa of gastric cancer relatives (2002) (36)
Impact of high-resolution transabdominal ultrasound in the diagnosis of complications of Crohn's disease (2010) (36)
Optimized serum pancreolauryl test for differentiating patients with and without chronic pancreatitis. (1998) (36)
Influence of Helicobacter pylori on gastric regulation of food intake (2009) (36)
A Frequent Toll‐Like Receptor 1 Gene Polymorphism Affects NK‐ and T‐cell IFN‐γ Production and is Associated with Helicobacter pylori‐induced Gastric Disease (2013) (35)
Helicobacter pylori eradication and gastric ulcer healing — comparison of three pantoprazole‐based triple therapies (2003) (35)
Role of Helicobacter pylori infection in gastric cancer pathogenesis: A chance for prevention (2010) (35)
Treatment of Helicobacter pylori. (2007) (35)
Atropine antagonizes cholecystokinin and cerulein-induced gallbladder evacuation in man: a real-time ultrasonographic study. (1985) (35)
Protective role of heat shock protein 27 in gastric mucosal injury (2005) (35)
Oxyntic gastric atrophy in Helicobacter pylori gastritis is distinct from autoimmune gastritis (2016) (35)
Helicobacter pylori Infection: New Facts in Clinical Management (2018) (35)
Balloon-assisted enteroscopy: unifying double-balloon and single-balloon enteroscopy. (2008) (35)
The penetration of antibiotics into human pancreas (2005) (35)
Causes and Mechanisms in Acute Pancreatitis (2010) (35)
Utility of Double-Balloon Enteroscopy for the Evaluation of Malabsorption (2008) (35)
Effect of omeprazole on Helicobacter pylori urease activity in vivo. (1996) (35)
A multicenter study on the role of direct retrograde cholangioscopy in patients with inconclusive endoscopic retrograde cholangiography (2013) (35)
Clinical Characteristics and Time Trends in Etiology of Hepatocellular Cancer in Germany (2013) (35)
The european meeting on Helicobacter pylori: therapeutic news from Lisbon (1998) (34)
Helicobacter pylori Infection and the Respiratory System: A Systematic Review of the Literature (2011) (34)
Double‐balloon enteroscopy in the diagnosis of suspected isolated Crohn's disease of the small bowel (2014) (34)
Genome and Methylome Variation in Helicobacter pylori With a cag Pathogenicity Island During Early Stages of Human Infection. (2017) (34)
H. pylori and its modulation of gastrointestinal microbiota (2015) (34)
Health‐related quality of life in patients with gastro‐oesophageal reflux disease under routine care: 5‐year follow‐up results of the ProGERD study (2009) (34)
Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer (2003) (34)
The Iceman’s Last Meal Consisted of Fat, Wild Meat, and Cereals (2018) (34)
Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic (2007) (33)
Identification of the thrombin light chain a as the single best mass for differentiation of gastric cancer patients from individuals with dyspepsia by proteome analysis. (2005) (33)
Laparoscopic-Endoscopic Rendezvous Resection of Upper Gastrointestinal Tumors (2005) (33)
Serum elastase 1 in inflammatory pancreatic and gastrointestinal diseases and in renal insufficiency. A comparison with other serum pancreatic enzymes (1987) (33)
Risk factors for failure of endoscopic stenting of biliary strictures in chronic pancreatitis: a prospective follow-up study. (2003) (33)
Addition of glucose to a fatty meal delays chylomicrons and suppresses VLDL in healthy subjects (2002) (33)
Role of aging in the expression of Helicobacter pylori gastritis in the antrum, corpus, and cardia. (1999) (33)
A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection (2019) (33)
Identification of Clinical and Laboratory Markers for Predicting Eosinophilic Esophagitis in Adults (2011) (32)
Ultrastructural localisation of urease in outer membrane and periplasm of Campylobacter pylori. (1989) (32)
Incidence, clinical management and outcomes of esophageal perforations after endoscopic dilatation. (2007) (32)
Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors. (2008) (32)
In vitro inhibition of Helicobacter pylori urease: biochemical and ultrastructural analysis (1991) (32)
Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity independently (1998) (32)
Omeprazole‐Based Dual and Triple Therapy for the Treatment of Helicobacter pylori Infection in Peptic Ulcer Disease: A Randomized Trial (1997) (32)
Validity of a Helicobacter pylori stool antigen assay for the assessment of H. pylori status following eradication therapy (2001) (32)
Nutrition and Hepatocellular Cancer (2015) (32)
Vitamin B12 and folic acid deficiency in chronic pancreatitis: a relevant disorder? (1991) (32)
Role of the pancreas in the control of interdigestive gastrointestinal motility. (1989) (31)
Informed Consent for Gastrointestinal Endoscopy: A 2002 ESGE Survey (2003) (31)
Management of Reflux Symptoms with Over-the-Counter Proton Pump Inhibitors: Issues and Proposed Guidelines (2009) (31)
Octreotide in the treatment of acute pancreatitis: results of a unicenter prospective trial with three different octreotide dosages. (1994) (31)
Molecular diagnostics in gastric cancer. (2014) (31)
Helicobacter Pylori Infection. (2018) (31)
Inhibition of human exocrine pancreatic secretion by the long‐acting somatostatin analogue octreotide (SMS 201‐995) (1992) (31)
[Guidelines of the German Society of Digestive and Metabolic Diseases for treatment of dyspepsia]. (2001) (31)
Peptic ulcer pathogenesis (1995) (31)
Chronic pancreatitis: management of pain. (1994) (31)
Treating critically ill patients with probiotics: Beneficial or dangerous? (2011) (31)
Clinical utility of the serum pancreolauryl test in diagnosis and staging of chronic pancreatitis. (1993) (31)
Overexpression of Platelet-Derived Growth Factor (PDGF) B Chain and Type β PDGF Receptor in Human Chronic Pancreatitis (1998) (31)
Clinical picture and diagnosis of acute pancreatitis. (1991) (31)
CD8+CD103+ T cells analogous to intestinal intraepithelial lymphocytes infiltrate the pancreas in chronic pancreatitis. (1998) (31)
Dyspepsia and Helicobacter pylori (2008) (31)
Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms are not associated with premalignant gastric conditions: a combined haplotype analysis (2010) (31)
How Do Practicing Clinicians Manage Helicobacter pylori‐Related Gastrointestinal Diseases in Germany? A Survey of Gastroenterologists and Family Practitioners (1998) (31)
13C-urea breath test for the diagnosis of Helicobacter pylori infection. A further simplification for clinical practice. (1998) (30)
Enantioselective quantification of omeprazole and its main metabolites in human serum by chiral HPLC-atmospheric pressure photoionization tandem mass spectrometry. (2007) (30)
Helicobacter pylori and Gastric Cancer (2014) (30)
Quorum sensing in the probiotic bacterium Escherichia coli Nissle 1917 (Mutaflor) – evidence that furanosyl borate diester (AI-2) is influencing the cytokine expression in the DSS colitis mouse model (2012) (30)
Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up. (2002) (30)
H. pylori Infection and Visceral Hypersensitivity in Patients with Irritable Bowel Syndrome (2001) (30)
Critical issues in the pathophysiology and management of peptic ulcer disease. (1995) (30)
Helicobacter pylori: Gastric Cancer and Extragastric Intestinal Malignancies (2012) (30)
HIV/AIDS-related stigma felt by people living with HIV from Buea, Cameroon (2013) (29)
Gastroesophageal Reflux Disease and Management in Advanced Pregnancy: A Prospective Survey (2009) (29)
Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus (2006) (29)
Markers for Gastric Cancer Premalignant Lesions: Where Do We Go? (2012) (29)
Localization of TFF3 peptide in human esophageal submucosal glands and gastric cardia: differentiation of two types of gastric pit cells along the rostro-caudal axis (2007) (29)
Guidelines for treatment of Helicobacter pylori in the East and West (2011) (29)
A critical appraisal of probiotics (as drugs or food supplements) in gastrointestinal diseases (2014) (29)
Induction and expression of cyclin D3 in human pancreatic cancer (2001) (28)
Review article: From gastrin to gastro‐oesophageal reflux disease – a century of acid suppression (2006) (28)
Comparison of two tubeless function tests in the assessment of mild‐to‐moderate exocrine pancreatic insufficiency (2000) (28)
Somatic DNA Hypomethylation in H. pylori-Associated High-Risk Gastritis and Gastric Cancer: Enhanced Somatic Hypomethylation Associates with Advanced Stage Cancer (2015) (28)
The Association Between the Interleukin-1 Polymorphisms and Gastric Cancer Risk Depends on the Family History of Gastric Carcinoma in the Study Population (2006) (28)
Adaptation of the human pancreas to inhibition of luminal proteolytic activity. (1998) (28)
Effect of duodenectomy on interdigestive pancreatic secretion, gastrointestinal motility, and hormones in dogs. (1989) (28)
Ratios of different serum pancreatic enzymes in the diagnosis and staging of chronic pancreatitis. (1993) (28)
Metastatic Disease in the Stomach (2015) (28)
Management issues in dyspepsia: current consensus and controversies (2004) (28)
Gastric Cancer—Epidemiologic and Clinical Aspects (2014) (28)
Validation of a simplified carbon-14-urea breath test for routine use for detecting Helicobacter [correction of Heliobacter] pylori noninvasively. (1990) (28)
Helicobacter pylori eradication does not exacerbate gastro-oesophageal reflux disease (2004) (28)
Alteration of fibroblast growth factor and receptor expression after acute pancreatitis in humans. (1999) (28)
Serum ribonuclease activity in the diagnosis of pancreatic disease (1991) (27)
Molecular alterations in gastric cancer: the role of Helicobacter pylori. (2000) (27)
Diagnostic methods for H. pylori infection: Choices, opportunities and pitfalls (2015) (27)
Adaptive changes of the exocrine pancreas and plasma cholecystokinin release following subtotal gastric resection in rats. (1987) (27)
Helicobacter pylori and gastroesophageal reflux disease (2014) (27)
Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinoma (2006) (27)
A novel approach to esophageal stent removal in the setting of proximal stenosis and failure of the primary retrieval mechanism (2015) (27)
Correlation of serum pepsinogens and gastrin‐17 with atrophic gastritis in gastroesophageal reflux patients: A matched‐pairs study (2011) (27)
Cardia-type metaplasia arising in the remnant esophagus after cardia resection. (2004) (27)
Clinical Implications of Alpha-Fetoprotein Expression in Gastric Adenocarcinoma (2004) (26)
From chronic inflammation to cancer (2010) (26)
Role of the Duodenum in Postprandial Release of Pancreatic and Gastrointestinal Hormones (1994) (26)
Has education about Helicobacter pylori infection been effective? Worldwide survey of primary care physicians (2003) (26)
Editorial: Sequential Therapy for Eradication of Helicobacter pylori: A New Guiding Light or a False Dawn? (2009) (26)
Long‐term treatment of patients with gastro‐oesophageal reflux disease in routine care – results from the ProGERD study (2007) (26)
Chromoendoscopy: From a Research Tool to Clinical Progress (2002) (26)
Non-Erosive Reflux Disease – Defining the Entity and Delineating the Management (2008) (26)
Clinical Aspects of Gastric Cancer and Helicobacter pylori– Screening, Prevention, and Treatment (2010) (26)
Multichannel Intraluminal Impedance and pH-Metry for Investigation of Symptomatic Gastroesophageal Reflux Disease (2007) (26)
European Registry on Helicobacter pylori management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice (2020) (26)
Prognostic factors in acute pancreatitis (1993) (26)
Biochemical Staging of Acute Pancreatitis (1987) (26)
Phase III of the migrating motor complex: associated with endogenous xenin plasma peaks and induced by exogenous xenin (2001) (26)
Diagnosis of Helicobacter pylori infection by HpSA test (1999) (26)
Helicobacter pylori “Test‐and‐Treat” strategy with urea breath test: A cost‐effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain—Results of the Hp‐Breath initiative (2020) (26)
Correlation of Imaging Procedures, Biochemical Parameters, and Clinical Stage in Acute Pancreatitis (1986) (25)
Preneoplastic Conditions in the Stomach: Always a Point of No Return (2014) (25)
Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma (2015) (25)
Polypectomy Techniques for Difficult Colon Polyps (2009) (25)
Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti‐inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors (2018) (25)
[Diagnosis and therapy of Helicobacter pylori infection. Guidelines of the German Society of Digestive and Metabolic Diseases]. (1996) (25)
Current concepts in dyspepsia: a world perspective. (1999) (25)
Identification and characterization of Helicobacter pylori phospholipase C activity. (1993) (25)
CD8+CD103+ T cells analogous to intestinal intraepithelial lymphocytes infiltrate the pancreas in chronic pancreatitis* (1998) (25)
Acute severe pancreatitis: contrast-enhanced sonography (2007) (25)
Functional Gastrointestinal Disorders: Complex Treatments for Complex Pathophysiological Mechanisms (2018) (24)
Formation of nitrite in gastric juice of patients with various gastric disorders after ingestion of a standard dose of nitrate--a possible risk factor in gastric carcinogenesis. (1984) (24)
Helicobacter pylori: Gastric Cancer and Extragastric Malignancies – Clinical aspects (2013) (24)
Immunopathogenesis of chronic pancreatitis. (1998) (24)
Review article: Pathogenesis of sporadic and familial gastric cancer--implications for clinical management and cancer prevention. (2002) (24)
Helicobacter pylori and Gastrointestinal Malignancies (2015) (24)
Contrast-enhanced sonography in pancreatic diseases. (2007) (24)
Gene polymorphisms of the NOD-2/CARD-15 gene and the risk of gastric cancer in Germany. (2008) (24)
Interaction of Helicobacter pylori Infection and Nonsteroidal Anti‐Inflammatory Drugs in Gastric and Duodenal Ulcers (2010) (24)
Helicobacter pylori and Clinical Aspects of Gastric Cancer (2009) (24)
Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis (2007) (24)
Radioablation by Image-Guided (HDR) Brachytherapy and Transarterial Chemoembolization in Hepatocellular Carcinoma: A Randomized Phase II Trial (2018) (24)
A ‘Double-Balloon Enteroscopy Worth the Money’: Endoscopic Removal of a Coin Lodged in the Small Bowel (2009) (24)
Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers (2010) (24)
α-Catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives (2000) (24)
Effects of low‐dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin‐E2 do not depend on Helicobacter pylori infection (2006) (24)
Esomeprazole‐induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: Evidence from clinical and pharmacokinetic data (2005) (24)
Gastric cancer in autoimmune gastritis: A case-control study from the German centers of the staR project on gastric cancer research (2019) (24)
Helicobacter pylori and clinical risks—focus on gastro‐oesophageal reflux disease (2002) (24)
Impact of the angulus biopsy for the detection of gastric preneoplastic conditions and gastric cancer risk assessment (2015) (24)
Echo-enhanced ultrasound with pulse inversion imaging: A new imaging modality for the differentiation of cystic pancreatic tumours. (2006) (23)
STW 5 (Iberogast) Therapy in Gastrointestinal Functional Disorders (2018) (23)
Imatinib for hepatocellular cancer--focus on pharmacokinetic/pharmacodynamic modelling and liver function. (2008) (23)
Unmet Medical Needs among Patients with Gastroesophageal Reflux Disease: A Foundation for Improving Management in Primary Care (2009) (23)
Does H. pylori Eradication Therapy Benefit Patients With Hepatic Encephalopathy?: Systematic Review (2014) (23)
Functional involvement of cathepsin W in the cytotoxic activity of NK‐92 cells (2003) (23)
Inhibition of pancreatic secretion under long-term octreotide treatment in humans. (1994) (23)
PSCA and MUC1 gene polymorphisms are associated with gastric cancer and pre-malignant gastric conditions [corrected]. (2014) (23)
Performance of a Rapid Whole Blood Test for Helicobacter pylori in Primary Care: A German Multicenter Study (1998) (23)
Prognostic Parameters Determining Survival in Pancreatic Carcinoma and, in Particular, after Palliative Treatment (2001) (23)
Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD (2011) (23)
Helicobacter pylori-Mediated Gastritis Induces Local Downregulation of Secretory Leukocyte Protease Inhibitor in the Antrum (2004) (23)
Food‐Derived Xeno‐microRNAs: Influence of Diet and Detectability in Gastrointestinal Tract—Proof‐of‐Principle Study (2018) (23)
The effect of zolimidine, imidazopyridine-derivate, on the duodenal ulcer healing. (1979) (23)
Indications for endoscopic or surgical therapy in chronic pancreatitis. (1991) (23)
Prevalence ofHelicobacter pylori resistance to several antimicrobial agents in a region of Germany (1998) (23)
Morphologic, Genetic, and Biochemical Characterization of Helicobacter Magdeburgensis, a Novel Species Isolated from the Intestine of Laboratory Mice (2010) (22)
Functional and Topological Properties in Hepatocellular Carcinoma Transcriptome (2012) (22)
Endoscopic peroral jejunal fecal microbiota transplantation. (2016) (22)
Therapeutic Double-Balloon Enteroscopy: A Binational, Three-Center Experience (2011) (22)
What constitutes failure for Helicobacter pylori eradication therapy? (2003) (22)
Epidemic Trends of Obesity with Impact on Metabolism and Digestive Diseases (2012) (22)
New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report. (1998) (22)
Quantification of Pancreatic Zinc Output as Pancreatic Function Test: Making the Secretin-Caerulein Test Applicable to Clinical Practice (2004) (22)
A Practical Approach to Patients with Refractory Helicobacter pylori Infection, or Who Are Re-Infected After Standard Therapy (1999) (22)
Helicobacter pylori infection and gastro-oesophageal reflux disease: coincidence or association? (2000) (22)
Peptic Ulcer: Chapter Closed? (2020) (22)
The association between non‐ulcer dyspepsia and Helicobacter pylori infection (1994) (22)
M1-muscarinic mechanisms regulate interdigestive cycling of motor and secretory activity in human upper gut (1996) (22)
Low‐dose aspirin reduces the gene expression of gastrokine‐1 in the antral mucosa of healthy subjects (2008) (22)
NEMESIS: Noninferiority, Individual-Patient Metaanalysis of Selective Internal Radiation Therapy with 90Y Resin Microspheres Versus Sorafenib in Advanced Hepatocellular Carcinoma (2020) (22)
[Morphologic and functional changes in the pancreas following acute necrotizing pancreatitis]. (1985) (22)
Evaluation of an enzyme immunoassay for detecting Helicobacter pylori antigens in human stool samples. (1999) (22)
Helicobacter pylori Infection, Vitamin B12 and Homocysteine (2003) (21)
Dyspeptic symptoms associated with Helicobacter pylori infection are influenced by strain and host specific factors (2004) (21)
Prevention of Gastric Cancer by Helicobacter pylori Eradication? (2002) (21)
Endoscopic Therapy of Chronic Pancreatitis (2005) (21)
Ultrastructural localization of urease ofHelicobacter pylori (1993) (21)
Exocrine pancreatic function in the early recovery phase of acute oedematous pancreatitis (1992) (21)
Prevalence of H pylori associated "high risk gastritis" for development of gastric cancer in patients with normal endoscopic findings. (2006) (21)
Diagnostics of Helicobacter pylori infection in patients with peptic ulcer bleeding. (2004) (21)
Helicobacter pylori Infection in the Elderly (2003) (21)
Interleukin 1 beta (IL1B) gene polymorphisms are not associated with gastric carcinogenesis in Germany. (2010) (21)
Anti‐CagA and anti‐VacA antibodies in Helicobacter pylori‐infected patients with and without peptic ulcer disease in Serbia and Montenegro (2004) (21)
An International Primary Care Survey of GERD Terminology and Guidelines (2008) (21)
Ethical issues in endoscopy: patient satisfaction, safety in elderly patients, palliation, and relations with industry. Second European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, July 2006. (2007) (21)
Intercellular Space Volume Is Mainly Increased in the Basal Layer of Esophageal Squamous Epithelium in Patients with GERD (2011) (21)
Dual role of serum soluble E-cadherin as a biological marker of metastatic development in gastric cancer. (2003) (21)
Alterations of the p16/MTS1-tumor suppressor gene in gastric cancer. (1998) (21)
Bacterial Load and Degree of Gastric Mucosal Inflammation in Helicobacter pylori Infection (2011) (21)
Pancreatic Trophism Following Colectomy in Rats: The Potential Role of Gastrointestinal Hormones (1988) (20)
Correlation of High-Resolution Manometric Findings with Symptoms of Dysphagia and Endoscopic Features in Adults with Eosinophilic Esophagitis (2017) (20)
Polymorphisms of microRNA target genes IL12B, INSR, CCND1 and IL10 in gastric cancer (2017) (20)
Diagnostic and prognostic value of serum elastase 1 in acute pancreatitis (1986) (20)
Helicobacter pylori infection and fundic gastric atrophy are not associated with esophageal squamous cell carcinoma: a case–control study (2011) (20)
Pancreatic digestive function after subtotal gastrectomy--evaluation by an indirect method. (1984) (20)
Gastric adenocarcinoma with leptomeningeal carcinomatosis as the presenting manifestation: an autopsy case report. (2005) (20)
Helicobacter pylori Genotypes and Expression of Gastritis in Erosive Gastro-oesophageal Reflux Disease (2003) (20)
Hepatocellular Carcinoma: Current Concepts in Diagnosis, Staging and Treatment (2014) (20)
A Network Meta-Analysis of Randomized Controlled Trials on the Treatment of Eosinophilic Esophagitis in Adults and Children. (2020) (20)
Hepatomegaly and cholestasis as primary clinical manifestations of an AL-kappa amyloidosis. (1999) (20)
Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases (2006) (20)
Adenocarcinomas at different positions at the gastro-oesophageal junction show distinct association with gastritis and gastric preneoplastic conditions (2015) (20)
International Consensus on Diverticulosis and Diverticular Disease. Statements from the 3rd International Symposium on Diverticular Disease. (2020) (20)
Sorafenib Therapy in Patients with Advanced Hepatocellular Carcinoma in Advanced Liver Cirrhosis (2011) (20)
Helicobacter pylori in gastric lymphoma and carcinoma (1998) (20)
Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro‐oesophageal reflux disease: a matched case–control study (2008) (20)
Meta-analysis of single strain probiotics for the eradication of Helicobacter pylori and prevention of adverse events (2015) (19)
Helicobacter pylori infection (2010) (19)
Treatment of advanced pancreatic cancer with high-dose octreotide (1993) (19)
The Barrett‐associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma risk (2016) (19)
Breath and string test: a diagnostic package for the identification of treatment failure and antibiotic resistance of Helicobacter pylori without the necessity of upper gastrointestinal endoscopy. (2005) (19)
Independent cycles of exocrine pancreatic secretion, hormones and gastroduodenal motility in healthy fasting humans: reassessment of a complex partnership (1998) (19)
Seroprevalence of Helicobacter pylori in German Infants and Children (1997) (19)
The effect of oral pancreatic enzyme supplementation on the course and outcome of acute pancreatitis: a randomized, double-blind parallel-group study. (2014) (19)
Dysregulation of CDX1, CDX2 and SOX2 in patients with gastric cancer also affects the non-malignant mucosa (2013) (19)
Virulence Factors of Helicobacter pylori — Ultrastructural Features (1990) (19)
Helicobacter pylori vacA genotype is a predominant determinant of immune response to Helicobacter pylori CagA (2017) (19)
CD8+CD103+ T cells analogous to intestinal intraepithelial lymphocytes infiltrate the pancreas in chronic pancreatitis (1998) (19)
[Effect of pancreatin on diabetes mellitus in chronic pancreatitis]. (1990) (18)
Other Helicobacters and gastric microbiota (2016) (18)
Detection of a Putative Novel Wolinella Species in Patients with Squamous Cell Carcinoma of the Esophagus (2003) (18)
Pazopanib and 5-FU/oxaliplatin as first-line treatment in advanced gastric cancer: PaFLO, a randomized phase II study from the AIO (Arbeitsgemeinschaft Internistische Onkologie). (2015) (18)
Gastrointestinal endoscopy in the elderly: current issues. (2009) (18)
Adhesion of Helicobacter pylori and Escherichia coli to human and bovine surface mucus cells in vitro (1994) (18)
Helicobacter pylori and Gastroduodenal Pathology (1993) (18)
Effects of TRH on Pancreatic Growth and Secretion in Rats (1990) (18)
[Helicobacter pylori infection in pancreatic cancer]. (2012) (18)
Hepatocellular Carcinoma and Liver Cirrhosis: Assessment of the Liver Function after Yttrium-90 Radioembolization with Resin Microspheres or after CT-Guided High-Dose-Rate Brachytherapy (2009) (18)
[Diagnosis of necrotizing pancreatitis. Comparison between contrast medium-computed tomography and ultrasonics in a clinical study]. (2008) (18)
Gastro esophageal reflux disease is associated with absence from work: results from a prospective cohort study. (2005) (18)
IL‐17A and IL‐17F Gene Expression is Strongly Induced in the Mucosa of H. pylori‐Infected Subjects From Kenya and Germany (2010) (17)
Prevalence of Helicobacter pylori infection and gastric mucosal abnormalities in chronic pancreatitis (1998) (17)
Nonsteroidal Anti-Inflammatory Drug-Induced Gastroduodenal Bleeding: Risk Factors and Prevention Strategies (2010) (17)
Recent Advances in Molecular Diagnosis and Therapy of Gastric Cancer (2005) (17)
Fine structure of active and healed duodenal ulcer. (1991) (17)
Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy (2018) (17)
Potential role of somatostatin and octreotide in the management of acute pancreatitis. (1994) (17)
Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy (2018) (17)
Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction (2019) (17)
TFF3 expression at the esophagogastric junction is increased in gastro-esophageal reflux disease (GERD) (2004) (17)
The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland. (2017) (17)
Upregulation of Leukotriene Receptors in Gastric Cancer (2011) (17)
Comparison of two enzyme immunoassays for the assessment of Helicobacter pylori status in stool specimens after eradication therapy. (2002) (17)
Acute exacerbation of autoimmune hepatitis induced by Twinrix. (2005) (17)
Eosinophilic Esophagitis - Treatment of Eosinophilic Esophagitis with Drugs: Corticosteroids (2014) (17)
Evidence for PTGER4,PSCA, and MBOAT7 as risk genes for gastric cancer on the genome and transcriptome level (2017) (17)
Expression of caveolin-1 in gastrointestinal and extraintestinal cancers (2003) (17)
Helicobacter and Digestive Malignancies (2006) (17)
Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers (2013) (17)
EGF and BMPs govern differentiation and patterning in human gastric glands. (2021) (17)
Expression of zinc transporters ZIP4, ZIP14 and ZnT9 in hepatic carcinogenesis-An immunohistochemical study. (2018) (17)
Whipple’s Disease: An Endoscopic and Histologic Study (2008) (17)
Helicobacter pylori screening: options and challenges (2016) (16)
Expression of aurora kinase A correlates with the Wnt‐modulator RACGAP1 in gastric cancer (2016) (16)
MMP2 and MMP7 at the invasive front of gastric cancer are not associated with mTOR expression (2015) (16)
Biliary Strictures Are Not the Cause of Pain in Patients With Chronic Pancreatitis (2004) (16)
Prevalence of Helicobacter pylori infection among blood donors in Saxony-Anhalt, Germany – a region at intermediate risk for gastric cancer (2017) (16)
Effect of exogenous pancreatic enzymes on gastrointestinal and pancreatic hormone release and gastrointestinal motility. (1993) (16)
Prevalence of Helicobacter pylori infection and dyspepsia in young adults in Germany. (1996) (16)
Endoscopy of the esophagus in gastroesophageal reflux disease: are we losing sight of symptoms? Another perspective. (2009) (16)
The impact of H. pylori on healing of reflux esophagitis during treatment with pantoprazole (1998) (16)
Expression of G1 Phase Cyclins in Human Gastric Cancer and Gastric Mucosa of First-Degree Relatives (2002) (16)
Expression of cyclin genes in human gastric cancer and in first degree relatives. (2002) (15)
Upper gastrointestinal diseases in the elderly: report of a meeting held at Vicenza, Italy, on 20 March 1998. (1999) (15)
Impact of Extrahepatic Metastases on Overall Survival in Patients with Advanced Liver Dominant Hepatocellular Carcinoma: A Subanalysis of the SORAMIC Trial (2020) (15)
Host polymorphisms of immune regulatory genes as risk factors for gastric cancer. (2009) (15)
Generalized AA-amyloidosis in a 58-year-old Caucasian woman with an 18-month history of gastrointestinal tuberculosis (1999) (15)
The effect of Helicobacter pylori infection and eradication in patients with gastro-oesophageal reflux disease: A parallel-group, double-blind, placebo-controlled multicentre study (2013) (15)
Review: Prevention and management of gastric cancer (2020) (15)
Expression of peroxisome proliferator-activated receptor delta in human gastric cancer and its response to specific COX-2 inhibitor. (2005) (15)
TLR1 and PRKAA1 Gene Polymorphisms in the Development of Atrophic Gastritis and Gastric Cancer. (2018) (15)
Cholecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy (1995) (15)
Helicobacter pylori eradication therapy is not associated with the onset of inflammatory bowel diseases. A case-control study. (2018) (15)
Gastric Epithelial Expression of IL-12 Cytokine Family in Helicobacter pylori Infection in Human: Is it Head or Tail of the Coin? (2013) (15)
[Preventing the recurrence of common bile duct calculi following endoscopic papillotomy with ursodeoxycholic acid]. (1990) (15)
An Introductory Course for Training in Endoscopy (2003) (15)
Historical Impact to Drive Research in Peptic Ulcer Disease (2011) (15)
Distinct TPEF/HPP1 gene methylation patterns in gastric cancer indicate a field effect in gastric carcinogenesis. (2008) (15)
Helicobacter pylori eradication in functional dyspepsia: new evidence for symptomatic benefit. (2001) (15)
Gastro‐oesophageal reflux disease is associated with up‐regulation of desmosomal components in oesophageal mucosa (2012) (15)
Does Helicobacter pylori status affect nonsteroidal anti-inflammatory drug-associated gastroduodenal pathology? (1998) (15)
Statistical annex: statistical aspects of clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. (1997) (15)
Decision-making in dyspepsia: controversies in primary and secondary care. (1999) (15)
Characterization of yellow plaques found in the small bowel during double-balloon enteroscopy. (2007) (15)
Implications of growth factor alterations in the treatment of pancreatic cancer (2003) (15)
Analysis of K‐ras gene mutations in rare pancreatic and ampullary tumours (1998) (15)
Serum phospholipase A2 in intensive care patients with peritonitis, multiple injury, and necrotizing pancreatitis (1989) (15)
GERD assessment including pH metry predicts a high response rate to PPI standard therapy (2013) (15)
RiMINI – the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial (2016) (14)
Evaluation of a near-patient fecal antigen test for the assessment of Helicobacter pylori status. (2004) (14)
Combined Gastric and Colorectal Cancer Screening—A New Strategy (2018) (14)
Expression of microRNAs in the ascites of patients with peritoneal carcinomatosis and peritonitis (2018) (14)
Helicobacter pylori infection: selected aspects in clinical management (2013) (14)
1047 Efficacy of an Investigational Recombinant Antigen Based Vaccine Against a CagA H. pylori Infectious Challenge in Healthy Volunteers (2012) (14)
The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland. (2017) (14)
Modified Helicobacter test using a new test meal and a 13C-urea breath test in Helicobacter pylori positive and negative dyspepsia patients on proton pump inhibitors (2017) (14)
The Pathophysiology of Portal Hypertension (2005) (14)
Loss of Expression of Tumor Suppressor p16INK4 Protein in Human Primary Gastric Cancer Is Related to the Grade of Differentiation (2002) (14)
Clinical symptom tool that raises the index of suspicion for eosinophilic oesophagitis in adults and drives earlier biopsy for definitive diagnosis (2017) (14)
The Pancreas: Causes for Malabsorption (2014) (14)
Helicobacter pylori infection and molecular changes in gastric carcinogenesis (2008) (14)
Cholecystokinin influences pancreatic trophism following total gastrectomy in rats (1989) (14)
Maintenance Therapy with FOLFIRI after FOLFIRINOX for Advanced Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis (2019) (14)
Soluble thrombomodulin plasma levels are an early indication of a lethal course in human acute pancreatitis. (2002) (14)
Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction. (1994) (14)
Diagnosis of Helicobacter pylori infection by HpSA test. European Helicobacter pylori HpSA Study Group. (1999) (14)
A Randomised, Controlled Trial: Effect of a Multi-Strain Fermented Milk on the Gut Microbiota Recovery after Helicobacter pylori Therapy (2021) (14)
Impact of different anticancer regimens on biomarkers of angiogenesis in patients with advanced hepatocellular cancer (2009) (14)
Effect of cisapride on gastric sensitivity to distension, gastric compliance and duodeno-gastric reflexes in healthy humans. (2001) (13)
Clinical Symptoms and Signs and Diagnostic Requirements in Acute Pancreatitis (1987) (13)
The combined presence of H pylori infection and gastro-oesophageal reflux disease leads to an up-regulation of CDX2 gene expression in antrum and cardia (2009) (13)
Relationship between pancreatic function and pain in chronic pancreatitis. (1990) (13)
Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer (2017) (13)
Interdigestive cycling and post-prandial release of pancreatic polypeptide in severe obesity. (1990) (13)
Effect of oral pancreatic enzyme administration on digestive function in healthy subjects: comparison between two enzyme preparations (1997) (13)
Expression of inducible nitric oxide synthase in human gastric cancer. (1999) (13)
Inflammatory Myofibroblastic Tumor of the Pancreatic Head: An Unusual Cause of Recurrent Acute Pancreatitis – Case Presentation of a Palliative Approach after Failed Resection and Review of the Literature (2010) (13)
Authors' response: antibodies to GP2, the major zymogen granule membrane glycoprotein, are specific for Crohn's disease and may reflect treatment response (2011) (13)
Randomised clinical trial: the 5‐HT4 agonist revexepride in patients with gastro‐oesophageal reflux disease who have persistent symptoms despite PPI therapy (2015) (13)
Pancreatic trophism after truncal vagotomy in rats. (1987) (13)
Extraesophageal symptoms of gastroesophageal reflux disease during pregnancy (2015) (13)
Consensus Report infection: the Maastricht III Helicobacter pylori Current concepts in the management of (2007) (13)
Helicobacter pylori and proteolytic activity (1996) (12)
Comparison of different endocrine stimulation tests in nondiabetic patients with chronic pancreatitis. (1998) (12)
Influence of extrapancreatic digestive disorders on the indirect pancreatic function test with fluorescein dilaurate. (1985) (12)
The Maastricht recommendations and their impact on general practice. (1999) (12)
Gastric metaplasia and Campylobacter pylori in duodenal ulcer disease: an ultrastructural analysis. (1989) (12)
Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice. (2007) (12)
Nocturnal Gastric Acid Breakthrough Is Not Associated with Night-Time Gastroesophageal Reflux in GERD Patients (2009) (12)
PEPDar: A randomized prospective noninferiority study of ritonavir‐boosted darunavir for HIV post‐exposure prophylaxis (2016) (12)
Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori-negative patients (2022) (12)
Upregulation of cathepsin W-expressing T cells is specific for autoimmune atrophic gastritis compared to other types of chronic gastritis. (2005) (12)
World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013. (2014) (12)
An evidence-based, Latin-American consensus on gastro-oesophageal reflux disease (2006) (12)
Chronic erosive gastritis--a therapeutic approach with bismuth. (1988) (12)
Omeprazole-induced cough in a patient with gastroesophageal reflux disease. (2010) (12)
Clinical course of laryngo‐respiratory symptoms in gastro‐oesophageal reflux disease during routine care ‐ a 5‐year follow‐up (2009) (12)
[Polymorphism in Helicobacter pylori--a key function in recurrence of infection?]. (1992) (12)
[Diagnostic significance of pancreatic serum-enzyme patterns after stimulation with secretin in chronic pancreatitis (author's transl)]. (2008) (12)
[S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease]. (2016) (12)
[Eosinophilic esophagitis--pathogenesis, clinical presentation and therapeutic management]. (2007) (11)
Prevalence of Helicobacter pylori Infection in Patients with Minimal Hepatic Encephalopathy. (2016) (11)
Adaptive changes in rat exocrine pancreas following subtotal colectomy. (1987) (11)
Helicobacter pylori Recurrence in Patients with Duodenal Ulcer: Clinical, Endoscopic, Histologic, and Genotypic Aspects. A 10‐Year Brazilian Series (2006) (11)
Obscure overt GI bleeding secondary to angiodysplasias at the hepaticojejunostomy diagnosed and successfully treated with double-balloon enteroscopy. (2008) (11)
Polypharmacy—Time to Get Beyond Numbers (2017) (11)
Ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the morphologic diagnosis of pancreatic disease (1983) (11)
Strategies of Cancer Prevention in Gastroenterology (2009) (11)
Microarray analysis of gene expression in metastatic gastric cancer cells after incubation with the methylation inhibitor 5-aza-2′-deoxycytidine (2005) (11)
Direct peroral cholangioscopy using ultraslim gastroscopes: high technical performance with important diagnostic yield. (2014) (11)
Sonographic characteristics of intramural bowel hematoma (2008) (11)
Impact of gastroesophageal reflux disease symptoms on the quality of life in pregnant women: a prospective study (2017) (11)
Small-Bowel Metaplasia Arising in the Remnant Esophagus After Esophagogastrostomy—A Prospective Study in Patients with a History of Total Gastrectomy (2005) (11)
GERD Evaluation: Time for a New Paradigm? (2007) (11)
The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma – a substudy of the SORAMIC trial (2020) (11)
Pathogenesis of Diverticulosis and Diverticular Disease. (2020) (11)
Is typing of metaplasia at the squamocolumnar junction revealing its aetiology? (2000) (11)
Double-balloon enteroscopy: beyond feasibility, what do we do now? (2007) (11)
[The H2-lactulose breath test in the diagnosis of intestinal transit time]. (1990) (11)
Esomeprazole therapy improves sleep disorders in patients with gastroesophageal reflux disease (GERD): A report from the ProGerd study (2003) (11)
Leukotriene receptor expression in esophageal squamous cell cancer and non-transformed esophageal epithelium: a matched case control study (2016) (11)
M1 muscarinic mechanisms regulate intestinal-phase gallbladder physiology in humans. (1996) (11)
Proton Pump Inhibitors: A Balanced View (2013) (11)
Secretory leukocyte protease inhibitor expression in various types of gastritis: a specific role of Helicobacter pylori infection (2006) (11)
179 Quadruple Therapy With Bismuth Subcitrate Potassium, Metronidazole, Tetracycline, and Omeprazole is Superior to Triple Therapy With Omeprazole, Amoxicillin, and Clarithromycin in the Eradication of Helicobacter pylori (2010) (11)
Increased risk for Helicobacter pylori recurrence by continuous acid suppression: a randomized controlled study. (1998) (11)
Safe administration of S-1 after 5-fluorouracil-induced cardiotoxicity in a patient with colorectal cancer (2017) (11)
[Immunotherapy of advanced pancreatic carcinoma with the monoclonal antibody BW 494]. (2008) (11)
728PFINAL ANALYSIS OF OVERALL SURVIVAL PER SUBGROUPS OF HCC PATIENTS IN THE PROSPECTIVE, NON-INTERVENTIONAL INSIGHT STUDY TREATED WITH SORAFENIB. (2014) (11)
Blue Light Imaging and Linked Color Imaging for the Characterization of Mucosal Changes in Chronic Gastritis: A Clinicians View and Brief Technical Report (2019) (11)
Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma (2021) (10)
THE MAASTRICHT GUIDELINES AND OTHER INNOVATIONS (1997) (10)
Helicobacter pylori Infection, but not Low‐Dose Aspirin, Results in a Local Reduction of the Secretory Leukocyte Protease Inhibitor in Gastroduodenal Mucosa (2006) (10)
Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction (2022) (10)
Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches (2019) (10)
Gastric Atrophy Reversible or Irreversible after Helicobacter pylori Eradication – An Open Question (2011) (10)
Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the 'burden of therapy' method. (2021) (10)
Chemoprevention of Adenocarcinoma Associated with Barrett’s Esophagus: Potential Options (2009) (10)
Down-Regulation of Secretory Leukocyte Protease Inhibitor Expression in Gastric Mucosa Is a General Phenomenon in Helicobacter pylori-Related Gastroduodenal Diseases (2005) (10)
Simultaneous Detection and Differentiation of Anti-Helicobacter pylori Antibodies by Flow Microparticle Immunofluorescence Assay (2004) (10)
[The fluorescein dilaurate serum test following metoclopramide and secretin stimulation for evaluating pancreatic function. Contribution to the diagnosis of chronic pancreatitis]. (1987) (10)
Cholangitis as a late complication of choledochoduodenostomy: the sump syndrome. (2009) (10)
Technical improvement using ultra‐slim gastroscopes for direct peroral cholangioscopy: analysis of the initial learning phase (2015) (10)
Echo-Enhanced Sonography – An Increasingly Used Procedure for the Differentiation of Pancreatic Tumors (2004) (10)
The long-term effect of Helicobacter pylori eradication on COX-1/2, 5-LOX and leukotriene receptors in patients with a risk gastritis phenotype--a link to gastric carcinogenesis. (2008) (10)
Duodenal ulcer due to yttrium microspheres used for selective internal radiation therapy of hepatocellular cancer. (2009) (10)
[Diagnostic and therapeutic utility of double balloon endoscopy: experience with 225 procedures]. (2007) (10)
Prevention of Hepatocellular Carcinoma (2016) (10)
Helicobacter pylori infection in ulcer pathogenesis. (1997) (10)
Helicobacter pylori and Gastric Cancer: Timing and Impact of Preventive Measures. (2016) (10)
Pitfalls in Helicobacter pylori diagnosis (1998) (10)
Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression (2011) (10)
Chronic pancreatitis: diagnosis and staging. (2000) (10)
Rationale for eradication of Helicobacter pylori infection in duodenal ulcer disease. (1993) (10)
The Authors' reply (2011) (10)
Long-term outcome of self expandable metal stents for biliary obstruction in chronic pancreatitis. (2013) (10)
Zonulin is not increased in the cardiac and esophageal mucosa of patients with gastroesophageal reflux disease (2009) (9)
LINE-1 hypomethylation is not a common event in preneoplastic stages of gastric carcinogenesis (2017) (9)
Cadherins and catenins in inflammation and oncogenesis. (2000) (9)
Expression of cytokeratins in Helicobacter pylori-associated chronic gastritis of adult patients infected with cagA+ strains: an immunohistochemical study. (2006) (9)
Nighttime Heartburn in Patients with Gastroesophageal Reflux Disease under Routine Care (2008) (9)
Commentary: is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered? (2012) (9)
Elastase 1 in Acute Pancreatitis (1987) (9)
Sonographic diagnosis and endoscopic therapy of a biliopancreatic fistula complicating a pancreatic pseudocyst (2006) (9)
Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma. (2021) (9)
Recommendations of the ESGE workshop on Ethics in Teaching and Learning Endoscopy. First European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, June 2003. (2003) (9)
Pancreatic pseudocyst of the mediastinum. Evaluation by CT. (1986) (9)
A novel enzyme immunoassay for the direct detection of H. pylori antigens in stool (2001) (9)
Association of Long Non-Coding RNA Polymorphisms with Gastric Cancer and Atrophic Gastritis (2020) (9)
Influence of gastrointestinal hormones on human salivary secretion. (1980) (9)
Pseudomembranous colitis due to Salmonella enterica serotype infantis. (2006) (9)
[Secondary pancreatic insufficiency following distal stomach resection]. (1985) (9)
Short-term/low-dose aspirin-induced duodenal erosions are not dependent on Helicobacter pylori infection, cyclooxygenase expression and prostaglandin E2 levels (2008) (9)
Helicobacter pylori Infection - Management from a European Perspective (2014) (9)
Invasion of campylobacter-like organisms in the duodenal mucosa in patients with active duodenal ulcer (1987) (9)
Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial (2021) (9)
Carditis at the Interface between GERD and Helicobacter pylori Infection (2004) (9)
Nonerosive reflux disease: clinical concepts (2018) (9)
Impact of Helicobacter pylori infection on gastro-esophageal reflux (1998) (8)
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia (2015) (8)
Influence of high-dose pancreatic enzyme treatment on pancreatic function in healthy volunteers (1998) (8)
187 A PHASE I/II, OPEN-LABEL, DOSE-ESCALATION TRIAL USING THE ONCE-DAILY ORAL CHELATOR DEFERASIROX TO TREAT IRON OVERLOAD IN HFE-RELATED HEREDITARY HEMOCHROMATOSIS: FINAL RESULTS (2009) (8)
Current Concepts in the Management of Helicobacter pylori Infection - The Maastricht 2-2000 Consensus Report (Updated Contents) (2004) (8)
Rare Neoplasia of the Stomach (2015) (8)
Pancreatic Cancer Is ‘Always Non-Resectable’ (2007) (8)
[Gabexate mesilate in the therapy of acute pancreatitis. Multicenter study of tolerance of a high intravenous dose (4 g/day)]. (1988) (8)
S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease (2016) (8)
Helicobacter pylori and the pathogenesis of duodenal ulser disease (1993) (8)
Diagnosis and Staging of Acute Pancreatitis (1994) (8)
Helicobacter pylori and Other Gastric Bacteria (2011) (8)
Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors (2020) (8)
Validation of Two Calprotectin Rapid Tests in Daily Routine. (2016) (8)
Differentiation of cystic pancreatic lesions by echo-enhanced sonography with pulse inversion imaging - presentation of case reports. (2004) (8)
Tests for the Evaluation of Functional Gastrointestinal Disorders (2001) (8)
Whistler Summary: “The Slow Rate of Rapid Progress” (2007) (8)
Drug-induced liver disease related to citalopram. (2008) (8)
Helicobacter pylori– a Timeless Source of Lessons and Research Initiatives (2007) (8)
The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease (2017) (8)
Impact of operators experience on value of high-resolution transabdominal ultrasound in the diagnosis of choledocholithiasis: A prospective comparison using endoscopic retrograde cholangiography as gold standard (2006) (8)
Phase I Safety and Immunogenicity of A Three‐Component H. Pylori Vaccine (2003) (8)
IgA-Tissue Transglutaminase (tTG)-Antibodies Are Highly Sensitive Serum Markers for Celiac Disease (1999) (8)
Multiple cyanoacrylate (Histoacryl) emboli after injection therapy of cardia varices. (2009) (8)
Pseudoaneurysm of the Splenic Artery (2006) (7)
Helicobacter pylori and Non‐malignant Diseases (2005) (7)
Cone-beam computed tomography – adding a new dimension to ERCP (2015) (7)
Use of a colonoscope to perform endoscopic therapy in patients with active bleeding from posterior duodenal and gastric ulcers. (2009) (7)
Elimination of Helicobacter pylori by single shot antibiotic treatment in patients undergoing proximal gastric vagotomy (1992) (7)
Gastrointestinal Motility in Chronic Pancreatitis (1990) (7)
Consensus Report of the Third International Forum for Liver Magnetic Resonance Imaging (2010) (7)
Genome-Wide Analysis of Barrett's Adenocarcinoma. A First Step Towards Identifying Patients at Risk and Developing Therapeutic Paths12 (2017) (7)
The Prevalence of Helicobacter pylori Infection and the Pattern of Gastritis in Barrett’s Esophagus (2001) (7)
[Non steroidal anti-inflammatory drugs (NSAIDs) - balancing gastrointestinal complications and the cardiovascular risk]. (2009) (7)
Chairmen's Summary (1996) (7)
Relationship of Helicobacter pylori infection with gastrointestinal motility. (1999) (7)
Nonparallel patterns of circadian pancreatic and biliary secretions in fasting rats (1992) (7)
Gut peptide-mediated adaptive response of the exocrine pancreas. (1988) (7)
Helicobacter pylori infection and peptic ulcer disease (1999) (7)
Prevention of gastric cancer: a challenging but feasible task. (2007) (7)
Chronic Mucosal Inflammation of the Gastric Cardia in Gastroesophageal Reflux Disease Is Not Regulated by FOXP3-Expressing T cells (2009) (7)
The year in Helicobacter pylori 2000. (2000) (7)
Emergency double balloon enteroscopy: a feasible and promising diagnostic as well as possible therapeutic option in recurrent midgut bleeding (2011) (7)
Efficacy of Helicobacter pylori eradication in uninvestigated chronic dyspeptic staff members of a large factory: a prospective, long-term, follow-up, workplace outcome study (2002) (7)
[Ct-morphology and exocrine function in chronic pancreatitis]. (1983) (7)
Acute Pancreatitis: Treatment Strategies (2003) (7)
Influence of laboratory-related and endoscopy-related factors on the assessment of serum pepsinogens and gastrin-17 (2017) (7)
[Stress-ulcer prevention with pirenzepine-a controlled study]. (1980) (7)
Octreotide alone or in combination with rofecoxib as palliative treatment for advanced hepatocellular cancer. (2007) (7)
Diseases of the Pancreas: Acute Pancreatitis, Chronic Pancreatitis, Neoplasms of the Pancreas (2004) (7)
Determination of pancreatic lipase by immunoactivation technology. A rapid test system with high sensitivity and specificity. (1992) (7)
Review: Eradication of H. pylori infection: the challenge is on if standard therapy fails (2009) (7)
Superiority of a Split-dose Regimen of Sodium Picosulfate/Magnesium Citrate (SPMC) in Comparison to a Prior-day Schedule (AM/PM) for Colonoscopy Preparation. A Randomized Single-blinded Study. (2016) (7)
Relationship between postprandial release of CCK and PP in health and in chronic pancreatitis (1994) (7)
“My Friend with HIV Remains a Friend”: HIV/AIDS Stigma Reduction through Education in Secondary Schools—A Pilot Project in Buea, Cameroon (2020) (7)
Lectin UEA-I-Binding Proteins Are Specifically Increased in the Squamous Epithelium of Patients with Barrett’s Esophagus (2009) (6)
Multi-target Treatment for Irritable Bowel Syndrome with STW 5: Pharmacological Modes of Action. (2020) (6)
[Gastrointestinal neuroendocrine tumors]. (2008) (6)
How to improve the 13C-urea breath test (UBT) for the diagnosis of H. pylori infection? (1995) (6)
Pre- and post-treatment diagnosis of H.pylori infection by the 13C-urea breath test (13C-UBT): Validation of a new isotope-selective infrared spectrometer (ISIS) (2000) (6)
Impact of endoscopy-based research on quality of life in healthy volunteers. (2010) (6)
[Severe hyperemesis gravidarum--pathophysiologic observations and new therapeutic approach]. (1991) (6)
The schilling test cannot be replaced by an absorption test with unlabeled vitamin B12 (1988) (6)
Echo-enhanced ultrasound—a new imaging modality for the differentiation of pancreatic lesions (2006) (6)
[Sonographic diagnosis of a liver abscess caused by an enterohepatic fistula in a patient with Crohn's disease]. (2006) (6)
Gastrointestinal tumors, non-colorectal (2012) (6)
Advanced Imaging Modalities (2004) (6)
Management of Helicobacter pylori Infection: What Should the Surgeon Know (2017) (6)
[Helicobacter pylori infection--an update for 2004]. (2004) (6)
Anatomy-shaped design of a fully-covered, biliary, self-expandable metal stent for treatment of benign distal biliary strictures (2015) (6)
Therapeutic strategies for the treatment of dyspepsia (2010) (6)
Hepatobiliary and pancreatic: Gallbladder varices (2006) (6)
SonoCT improves on conventional ultrasound in the visualization of the pancreatic and bile duct: A pilot study (2006) (6)
In vitro glycoprotein synthesis and secretion by gastric mucosal tissue of patients with gastritis. (1986) (6)
Helicobacter pylori and Nonmalignant Diseases (2004) (6)
Protease‐Activated Receptor‐2 (PAR2) in Human Gastric Mucosa as Mediator of Proinflammatory Effects in Helicobacter pylori Infection (2011) (6)
[The diagnostic value of the amino acid absorption test in detection of a disorder of exocrine pancreatic function]. (1992) (6)
Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions—A debate: Con (2007) (6)
The Rationale and Efficacy of Primary and Secondary Prevention in Adenocarcinomas of the Upper Gastrointestinal Tract (2019) (6)
A Risk-Benefit Assessment of Drugs Used in the Eradication of Helicobacter pylori Infection (1996) (6)
Effect of Intraduodenal Administration of Ursodeoxycholic Acid on Interdigestive Interaction between Gallbladder Motility, Pancreatic Secretion and Endocrine Activity (2004) (6)
Gallbladder dynamics in chronic pancreatitis (1993) (6)
Endoscopic intraductal radiofrequency ablation of remnant intrapapillary mucinous neoplasm with acute hemorrhage after incomplete surgical resection (2014) (6)
Endocrine Pancreatic Function in the Diagnosis and Staging of Chronic Pancreatitis (1997) (6)
Helicobacter pylori and functional dyspepsia (2001) (6)
Gastroesophageal reflux disease does not lead to changes in the secretory leukocyte protease inhibitor expression in esophageal mucosa (2009) (6)
pH-Hp: decisive new evidence. Chairmen??s introduction (1999) (6)
The effectiveness of selective internal radiation therapy in challenging cases of liver-predominant unresectable hepatocellular carcinoma. (2014) (6)
Prevention of Gastric Cancer by Helicobacter pylori Eradication (2005) (5)
Summary:: key messages (2000) (5)
Whipple's Disease (2014) (5)
[Reflux esophagitis--a community-wide increase in incidence]. (2001) (5)
Gastritis: An Update in 2020 (2020) (5)
Faecal Calprotectin Useful for Clinical Differentiation of Microscopic Colitis and Irritable Bowel Syndrome (2011) (5)
Gastric Metaplasia in Duodenal Mucosa — Key Factor for H. pylori Colonization and Duodenal Ulcer Pathogenesis? (1990) (5)
Capsule Endoscopy (CE) Increases the Diagnostic Yield of Double Balloon Enteroscopy (DBE) in Patients Being Investigated for Obscure Gastrointestinal Bleeding (OGIB) (2009) (5)
WGO-OMGE Practice Guideline Dysphagia - January 2004 : Final Version : guidelines (2005) (5)
Evaluation of sorafenib in combination with local microtherapy guided by gadolinium-EOB-DTPA enhanced MRI in patients with inoperable hepatocellular carcinoma. (2011) (5)
COVID-19: Don't Neglect the Gastrointestinal Tract! (2020) (5)
Bile leak from the duct of Luschka. (2010) (5)
Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17-25]. (2018) (5)
New rapid Helicobacter pylori blood test based on dual detection of FliD and CagA antibodies for on-site testing. (2021) (5)
Inflammatory microRNAs in gastric mucosa are modulated by Helicobacter pylori infection and proton-pump inhibitors but not by aspirin or NSAIDs (2021) (5)
[What is new in treating Helicobacter pylori infection?]. (2015) (5)
[Crohn's disease associated with Takayasu's arteritis]. (2005) (5)
The impact of combining Selective Internal Radiation Therapy (SIRT) with sorafenib on overall survival in patients with advanced hepatocellular carcinoma: The SORAMIC trial palliative cohort. (2018) (5)
Diagnosis and Staging of Chronic Pancreatitis (1993) (5)
Reflux esophagitis or Helicobacter infection? - diagnostic value of the inflammatory pattern in metaplastic mucosa at the squamocolumnar junction. (2007) (5)
Update on Helicobacter pylori research. Dyspepsia. (1997) (5)
Correction: Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer (2015) (5)
[The role of caveolin-1 gene in carcinogenesis]. (2004) (5)
[C-reactive protein as a marker of inflammation and necrosis in gastroenterology]. (1987) (5)
[Acute abdomen in a patient with ANCA-associated vasculitis]. (2011) (5)
[Prevention, early diagnosis and therapy of gastric cancer]. (2016) (5)
The effect of single‐dose naproxen on eicosanoid formation in human gastroduodenal mucosa (2006) (5)
Assessment of the fibrogenetic activity in chronic pancreatitis (1993) (5)
A prospective and randomised clinical trial of the tyrosine kinase inhibitor imatinib mesylate as an initial therapy of advanced pancreatic cancer (2004) (5)
Endocrine Pancreatic Function During and Following Acute Pancreatitis (1997) (5)
Helicobacter Pylori Serology in Relation to Hepatitis C Virus Infection and IL28B Single Nucleotide Polymorphism (2018) (5)
GERD in 2010: Diagnosis, novel mechanisms of disease and promising agents (2011) (5)
Is the accuracy of isotope-selective non-dispersive infrared spectrometry (NDIRS) sufficient for determination of gastric emptying using the 13C-octanoic acid breath test (13C-OABT): Comparison with isotope-ratio mass spectrometry (IRMS) (2000) (5)
[Dilemma between gastroprotection and cardiovascular prevention]. (2010) (5)
Helicobacter pylori (2014) (5)
Diagnostic value of immunoreactive phospholipase A2 in acute pancreatitis (1989) (4)
Inhibitory effect of thyrotropin-releasing hormone on enzyme secretion from isolated rat pancreatic acinar cells. (1995) (4)
268 SAFETY AND TOXICITY OF THE COMBINATION OF Y90-RADIOEMBOLIZATION AND SORAFENIB IN ADVANCED HCC: AN INTERIM ANALYSIS OF THE EUROPEAN MULTICENTER TRIAL SORAMIC (2013) (4)
Identification of a novel isoform predominantly expressed in gastric tissue and a triple-base pair polymorphism of the cathepsin W gene. (2004) (4)
TV News and Concerns about – the EHEC-outbreak 2011 in Germany (2014) (4)
Recommendations of the ESGE workshop on Ethics in Gastrointestinal Endoscopy-Based Research. First European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, June 2003. (2003) (4)
Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization (2021) (4)
Helicobacter pylori eradication in dyspepsia: New evidence for symptomatic benefit. (2019) (4)
935 Effect of mGluR5 Negative Allosteric Modulator (NAM) ADX10059, Monotherapy, on Reflux Events and Lower Esophageal Sphincter (LES) Function in Patients With Gastro-Esophageal Reflux Disease (GERD) (2010) (4)
Hp test and treat strategy reduces both disease-related absenteeism from work, house-doctor consultations and antacid consumption in uninvestigated chronic dyspeptic staff members of a large factory (2001) (4)
Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib (2022) (4)
Eosinophile Ösophagitis – Neues zur Pathogenese, Diagnostik und Therapie (2014) (4)
Prognostic value of serum phospholipase A in acute pancreatitis (1989) (4)
Evaluation of a novel rapid H. pylori stool antigen test: Is a reliable diagnosis now possible in the doctor's office? (2003) (4)
Combined Systemic Chemotherapy and CT-Guided High-Dose-Rate Brachytherapy for Isolated Local Manifestation of Pancreatic Cancer after Surgical Resection (2018) (4)
One-week low-dose lansoprazole triple therapy for eradication of Helicobacter pylori: A large multicentre, randomised trial (2000) (4)
Helicobacter pylori related and non-related lesions in the stomach. (2011) (4)
[Standards and innovations in the diagnosis of gastroesophageal reflux disease]. (2007) (4)
Helicobacter pylori and molecular mechanisms of gastric carcinogenesis: targets for prevention and therapy (2004) (4)
Acid Inhibition and Peptic Ulcer - 100 Years of Carl Schwarz's Dictum: No Acid - No Ulcer (2016) (4)
Recurrent diffuse gastric bleeding as a leading symptom of gastrointestinal AL amyloidosis (2017) (4)
S2k-Leitlinie Gastrointestinale Infektionen und Morbus Whipple 1 S2k-guideline gastrointestinal infectious diseases and Whipple ’ s disease (2015) (4)
Pazopanib with 5‐FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase‐II study—The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO‐STO‐0510 (2021) (4)
[Guidelines for the diagnosis and treatment of H. pylori infection]. (2003) (4)
The magnified endoscopic view of cardia-type mucosa. (2004) (4)
The submucosal cushion does not improve the histologic evaluation of adenomatous colon polyps resected by snare polypectomy. (2011) (4)
Chairmen's summary: dichotomies and directions in acid-related disorders. (2004) (4)
[Chronic appendicitis. Recurrent abdominal pain in the right lower quadrant from the viewpoint of the internist]. (1999) (4)
What is the Relevance of Gastric Microbiota Beyond H. pylori? (2019) (4)
Efficacy and Safety of a Polysaccharide-Based Natural Substance Complex in the Treatment of Obesity and Other Metabolic Syndrome Components: A Systematic Review (2022) (4)
Diabetes Mellitus in Chronic Pancreatitis (1990) (4)
[Splenic granulomas - rare extraintestinal manifestation of Crohn's disease]. (2010) (4)
[Cephalic pancreatectomy with conservation of the duodenum in chronic pancreatitis with inflammatory lesions of the head of pancreas. Results of 15 years' experience]. (1989) (4)
Helicobacter pylori infection and short-term intake of low-dose aspirin have different effects on alpha-1 antitrypsin/alpha-1 peptidase inhibitor (α1-PI) levels in antral mucosa and peripheral blood (2008) (4)
[Palliative treatment in gastroenterology at the border to (abdominal) surgery]. (2010) (4)
Effect of Procainhydrochloride on Phospholipase A2 Catalytic Activity in Sodium Taurocholate-Induced Acute Experimental Pancreatitis in Rats (2010) (4)
Are Gastroenterologists Aware of the Role of Ethics Committees? (2003) (4)
Hepatobiliary and pancreatic: Gastrointestinal bleeding and pancreatic pseudocysts (2004) (4)
Molecular aspects in the diagnosis of gastric cancer. (2009) (4)
[Insufficient validity of a rapid blood test for diagnosis of Helicobacter pylori infection]. (2001) (4)
European multicentre validation trial of two new non-invasive tests for detection of antibody to H. pylori: Urine-based ELISA and rapid urine test (2001) (4)
Commentary: how, in whom, and when to diagnose Helicobacter pylori. (1997) (4)
Clinical and laboratory diagnosis of acute pancreatitis. (1995) (4)
Novel strategies in the prevention of gastric cancer. (2001) (4)
Gut microbiota profiles and the role of anti‐CdtB and anti‐vinculin antibodies in patients with functional gastrointestinal disorders (FGID) (2021) (4)
UEG Week 2016 Poster Presentations (2016) (4)
Helicobacter pylori and nonmalignant disease (2002) (4)
Cost-effectiveness modelling of use of urea breath test for the management of Helicobacter pylori-related dyspepsia and peptic ulcer in the UK (2021) (4)
Constitutive expression of peroxisome proliferator-activated receptor (PPAR) δ and γ in gastric carcinomas and non-neoplastic gastric mucosa (2001) (4)
[Helicobacter pylori: short overview on selected data from the history and their value for clinical medicine, in particular, surgery - what does the (general/abdominal) surgeon need to know]. (2014) (4)
T-cell receptor Valpha gene expression of infiltrating T cells in pancreatic cancer. (1998) (4)
Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial (2021) (4)
Differential Expression of Long Noncoding RNA HOTAIR in Intestinal Metaplasia and Gastric Cancer (2022) (4)
Gastrointestinal: Radiation proctitis (2007) (4)
Circulating Cell-Free DNA Combined to Magnetic Resonance Imaging for Early Detection of HCC in Patients with Liver Cirrhosis (2021) (4)
Impaired interdigestive pancreatic polypeptide release. Early hormonal disorder in chronic pancreatitis? (1994) (4)
Mucosal Two-Step Pathogenesis in Gastroesophageal Reflux Disease: Repeated Weakly Acidic Stimulation and Activation of Protease-Activated Receptor-2 on Mucosal Interleukin-8 Secretion (2018) (4)
Comparative evaluation of two hemagglutination tests for the detection of anti-Helicobacter pylori antibodies. (2001) (4)
113 A PROSPECTIVE RANDOMIZED TRIAL COMPARING HDR-BRACHYTHERAPY AND TRANSARTERIAL CHEMOEMBOLIZATION IN HEPATOCELLULAR CARCINOMA (2013) (3)
Impact of healthy aging on active bacterial assemblages throughout the gastrointestinal tract (2021) (3)
Eosinophile Ösophagitis – Neues zur Pathogenese, Diagnostik und Therapie (2017) (3)
Gastrointestinal bleeding in patients with Helicobacter pylori and dual platelet inhibition after myocardial infarction. (2021) (3)
Editorial: the non‐invasive diagnosis of atrophic gastritis (2017) (3)
Neoadjuvant treatment with cisplatin and S-1 in elderly patients with oesophagogastric adenocarcinoma and locoregional disease: Two case reports and review of the literature. (2017) (3)
[S2k guideline Helicobacter pylori and gastroduodenal ulcer disease 2016 - Statement on stress ulcer prophylaxis and optimized therapy]. (2017) (3)
Helicobacter pylori, the cardia and gastroesophageal reflux disease (1999) (3)
[Effect of chronic renal failure and hemodialysis on the pancreas-specific enzyme pattern in the serum]. (1990) (3)
Tolerability of sorafenib in the treatment of hepatocellular carcinoma (HCC) in patients with Child A and B liver cirrhosis. (2009) (3)
Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting (2015) (3)
Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial (2021) (3)
Learning Curve of Double Balloon Enteroscopy (2008) (3)
Author's response: Helicobacter pylori eradication and gastric cancer prevention (2013) (3)
The Helicobacter pylori vacA s1/m1 genotype is associated with gastric cancer in Germany (1998) (3)
Role of nutrients in pancreatic adaptation with implication of cholecystokinin release. (1988) (3)
Correlation Between the Grade of Activity of Type B Gastritis and Synthesis of Glycoproteins (1990) (3)
Epidemiology and clinical characterization of HCC in a tertiary center in eastern Germany. (2011) (3)
Oro-caecal transit time in patients with non-ulcer dyspepsia : role of chronic gastritis and Helicobacter pylori infection (1991) (3)
[The value of ultrasound and computerized tomography in detection of cystic changes in chronic pancreatitis]. (1992) (3)
Practice and principle: the influence of current research on our management of acid-related disorders. Summary: key messages. (2000) (3)
[Barrett carcinoma--diagnosis, screening, surveillance, endoscopic treatment, prevention]. (2007) (3)
Hepatobiliary and pancreatic: Spontaneous splenorenal shunts in portal hypertension (2006) (3)
Whipple's Disease. (2004) (3)
[Relations between gastrointestinal interdigestive motility and secretion]. (1991) (3)
Effects of microencapsulated vs. enteric-coated acetylsalicylic acid on gastric and duodenal mucosa: an endoscopic study. (1988) (3)
Circulating miR-21-5p level has limited prognostic value in patients with hepatocellular carcinoma and is influenced by renal function (2020) (3)
Osteoclast-like giant-cell tumour of the pancreas causing painful ampullary obstruction. (2007) (3)
13C-Urea Breath Test: Further Modification towards an Unrestricted Use (2005) (3)
Assessment of desmosomal components (desmoglein 1-3, plakoglobin) in cardia mucosa in relation to gastroesophageal reflux disease and Helicobacter pylori infection. (2012) (3)
[Helicobacter pylori--when and how do gastroenterologists treat themselves? A clinical and practical survey]. (1997) (3)
[Nutritional support in patients with acute pancreatitis]. (2009) (3)
Impaired interdigestive pancreatic polypeptide release (2005) (3)
Small-bowel metaplasia arising in the remnant esophagus after esophagojejunostomy--a [corrected] prospective study in patients with a history of total gastrectomy. (2005) (3)
[Simultaneous sonographic study of postprandial gastric emptying and gallbladder contraction]. (1992) (3)
Hot Topics in Medical Treatment of Diverticular Disease: Evidence Pro and Cons. (2020) (3)
Healthy Stomach Initiative: the stomach in health and disease. Preface. (2014) (3)
Gut microbial similarity in twins is driven by shared environment and aging (2022) (3)
Hyperlipidemia in acute pancreatitis (1991) (3)
Single Balloon Enteroscopy (SBE) Versus Double Balloon (DBE) ERCP in Patients with Roux-en-Y Anastomosis (2009) (3)
Utility of Double Balloon Enteroscopy for Surveillance in Intestinal Polyposis Syndromes (2008) (3)
Abstract form for the Irish Journal of Medical Science v workshop on gastroduodenal pathology and Helicobacter pylori July 5th — 7th 1992 — Dublin, Ireland (1992) (3)
What is the role of the primary care physician in the treatment of Helicobacter pylori infection (1996) (3)
Helicobacter pylori World Gastroenterology Organization Global Guideline. (2022) (3)
Recent Developments in Chemotherapy of Advanced Gastric Cancer (2005) (3)
Is endoscopic ultrasonography superior to multidetector CT for assessing pancreatic cancer? (2005) (2)
Endoscopic Ultrasound in the Diagnosis of Chronic Pancreatitis and Pancreatic Cancer (2004) (2)
Therapeutic Yield of Photodynamic Therapy for Hilar Cholangiocarcinoma (2011) (2)
Correlation of Morphological Lesions, Functional Changes, and Clinical Stages in Chronic Pancreatitis (1986) (2)
[Bismuth aluminate in gastroenterology. Therapeutic effects in chronic erosive Campylobacter pylori-associated gastritis]. (1989) (2)
Biochemical Markers in the Early Prognostic Evaluation of Acute Pancreatitis (1997) (2)
[Dissociation of serum kinetics of amylase and trypsin following stimulation with secretin and pancreozymin]. (1982) (2)
Consensus Report Helicobacter pylori infection - The Maastricht III Current concepts in the management of (2007) (2)
The influence of the Helicobacter pylori-infection on the ammonia levels and psychometric tests in cirrhotic patients (1997) (2)
Gastric pathophysiology – emphasis on acid secretion and gastrointestinal motility (1996) (2)
Potassium-competitive acid blocker and proton pump inhibitor-based regimens for first-line Helicobacter pylori eradication: a network meta-analysis (2022) (2)
Biomarkers for Gastric Cancer and the Related Premalignant Conditions (2014) (2)
The Place of Endoscopic Ultrasound in the Diagnosis of Chronic Pancreatitis (2007) (2)
Saliva versus serum antibodies for diagnosis of Helicobacter pylori infection (1995) (2)
The importance of the pretherapeutic cag-A status for the success of H. pylori eradication therapy (2001) (2)
Clarithromycin versus amoxycillin in a dual high-dose omeprazole-based regimen for H. pylori eradication (1995) (2)
[Helicobacter pylori infection and ulcer]. (1998) (2)
[Correct diagnosis for indication in gastroesophageal reflux disease]. (2005) (2)
Gastroesophageal reflux disease leads to major alterations in lectin-binding in the columnar epithelium of the gastroesophageal junction (2007) (2)
What constitutes failure of H. pylori eradication therapy (2003) (2)
Adjusted cut-off for H. pylori antigen stool test for determination of H.pylori status after eradication (2000) (2)
Management of H. pylori Infection in Europe (2016) (2)
Detection of jejunal carcinoid in a patient with obscure-overt gastrointestinal bleeding by double-balloon enteroscopy. (2008) (2)
H. pylori infection: a clinical overview (2010) (2)
Proteases in Helicobacter pylori-Mediated Diseases (2006) (2)
Retracted: Vacuoles of Acanthamoeba castellanii Behave as a Specialized Shelter (host) for Helicobacter pylori (2015) (2)
Gastrointestinal motility and hormones in obesity. (1994) (2)
Protease-protease inhibitor balance in the gastric mucosa. Influence of Helicobacter pylori infection. (2000) (2)
[Oral pancreas function test with FDL in the diagnosis of chronic pancreatitis]. (1983) (2)
Non-ulcer dyspepsia and patient management, including diagnosis and treatment. (2000) (2)
[Nitrogen balance during modified fasting (author's transl)]. (1980) (2)
[Chronic pancreatitis with inflammatory enlargement of the head of the pancreas. Early and late results following duodenum saving resection of the head of the pancreas]. (1988) (2)
Review article: managing the dyspeptic patient--an interactive discussion. (2001) (2)
Helicobacter Test INFAI (2009) (2)
[International consensus on reflux disease of the esophagus]. (2000) (2)
Virtual 3D‐cholangioscopy: Correlation with direct peroral cholangioscopy in a patient with papillary cholangiocarcinoma (2017) (2)
Titel Page / Table of Contents (2007) (2)
Expression pattern of cathepsin W isoforms in peripheral blood and gastroesophageal mucosa of patients with gastroesophageal reflux disease (2011) (2)
Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome (PFO) results from the phase 3 REACH study. (2015) (2)
Gastroduodenal Motility in Relation to Peptic Ulcer Pathogenesis and Helicobacter pylori Infection (1990) (2)
ERCP Using the Double Balloon Enteroscope in Patients with Roux En Y Anastomosis (2008) (2)
Small volume acid reflux in gastroesophageal reflux disease patients with hiatal hernia is only detectable by pH-metry but not by multichannel intraluminal impedance. (2013) (2)
A multinational survey of activities of daily living and GERD in clinical practice: Is prescription therapy adequate? (2003) (2)
Su1712 Superiority of Bismuth-Based Quadruple Therapy vs. Standard Triple Therapy for Empiric Primary Treatment of Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability (2012) (2)
Prognostic factors associated with treatment response to octreotide in advanced hepatocellular cancer (HCC). (2004) (2)
Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study (2019) (2)
965 Differentiation of Gastroesophageal Reflux Disease (GERD) and Functional Heartburn (FH) by Histopathological Changes in Patients With Refractory Heartburn (2012) (2)
Helicobacter pylori eradication in functional dyspepsia (FD) does not lead to an increase of reflux-related symptoms (2000) (2)
[Shoulder metastasis as the initial manifestation of hepatocellular carcinoma (HCC)]. (2002) (2)
Different Prevalence of Alarm, Dyspeptic and Reflux Symptoms in Patients with Cardia and Non-cardia Gastric Cancer. (2021) (2)
The DICA Endoscopic Classification for Diverticular Disease of the Colon Shows a Significant Interobserver Agreement among Community Endoscopists: an International Study. (2020) (2)
Learning Curve of Double-Balloon Enteroscopy (DBE) (2007) (2)
Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial (2022) (2)
Diagnosis of chronic pancreatitis (2007) (2)
The role of octreotide in human acute pancreatitis A multicenter study (1997) (2)
Su1896 Eosinophilic Esophagitis in Adults : Association With Esophageal Motor Dysfunction? (2013) (2)
Multi-strain fermented milk promotes gut microbiota recovery after Helicobacter pylori therapy: a randomised, controlled trial (2021) (2)
Mo1869 Inverse Correlation of H. pylori and Eosinophilic Esophagitis (2014) (2)
Assessment and monitoring of liver function by 13C-aminopyrine breath test after selective transarterial chemoembolisation of hepatocellular carcinoma (2015) (2)
THE ROLE OF RIFAXIMIN IN IRRITABLE BOWEL SYNDROME DERIVED FROM A NETWORK META-ANALYSIS OF RANDOMIZED CONTROL TRIALS (2020) (2)
Infection with Helicobacter heilmannii (formerly Gastrospirillum horminis): characterization, epidemiology and therapy (2000) (2)
Altered luminal surface hydrophobicity of non-inflammed mucosa in patients with Crohn's disease (1995) (2)
The German physician Walter Krienitz: A pioneer in gastric research (2007) (2)
Overexpression of transforming growth factor beta-1 (TGF-B1) is associated with reduced pten expression in pancreatic fibrosis and cancer (2000) (2)
Morphology of Nerves in Chronic Pancreatitis and the Interrelationship with Inflammatory Tissue (1990) (2)
[Thyrotropin releasing hormone: functions and importance in the gastrointestinal tract and pancreas]. (1993) (2)
Endoscopy-Based Research in Healthy Volunteers (2003) (2)
[Walter Krienitz--his life and intuitive description of bacteria in the stomach]. (2006) (2)
GERD: Endoscopic Assessment: A Reconciliation With Symptoms (2007) (2)
S 2 k-Leitlinie Gastrointestinale Infektionen und Morbus Whipple 1 S 2 k-guideline gastrointestinal infectious diseases and Whipple ’ s disease (2015) (2)
T1980 How Does GERD Evolve During a 5-Year Follow-Up Period? the Progerd Study (2008) (2)
[Yersinia enterocolitica infection with extraintestinal manifestations: case report and overview]. (1994) (2)
Molecular therapy of gastric cancer Review Article (2003) (2)
Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions—A debate: Con (2007) (2)
[Epidemiology and pathogenesis of Helicobacter pylori infection]. (1996) (2)
Influence of Helicobacter pylori Infection and Omeprazole Treatment on Gastric Regional CO2 (2003) (2)
Reflux esophagitis – a burning and increasing disease in the community (2001) (2)
Tu1555 Therapeutic Small Bowel Endoscopy Using Balloon-Assisted Enteroscopy: A Bi-National, Three-Center Experience (2011) (2)
Road Map fluoroscopy successfully guides endoscopic interventions in the esophagus (2017) (2)
Combined Functional and Morphological Diagnostic Approach in Chronic Pancreatitis (1986) (2)
O-005Ramucirumab (RAM) as second-Line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib: comprehensive results from the randomized phase III REACH study (2015) (2)
Response to Professor McColl (2005) (2)
Exocrine pancreatic function in severe obesity. (1986) (2)
The pH-Hp Challenge-From Mechanism to Management: Chairmen's Introduction (1996) (2)
Sorafenib in combination with local microtherapy guided by gadolinium-EOB-DTPA enhanced MRI in patients with inoperable hepatocellular carcinoma (HCC) (SORAMIC). (2012) (2)
Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib – results from a non-interventional multi-center study (2020) (2)
494 Health-Related Quality of Life in Patients with Gastroesophageal Reflux Disease Under Routine Care – A 5-Year Follow-Up from the Progerd Study (2009) (2)
[Endoscopic biliary drainage in patients with pancreatic cancer]. (2003) (2)
Role of H. pylori infection and gastritis phenolype in erosive vs non erosive gastroesophageal reflux disease (GERD) — Anlyysis based on the proGERD study initiative (2001) (2)
Hepa-index, a New Biomarker Indicator of Hepatic Fibrosis in Patients with Chronic Liver Disease (2012) (2)
Gastrointestinal and Gallbladder Motility in Chronic Pancreatitis (1991) (2)
H. pylori eradication and ulcer size: Critical determinants for gastric ulcer (GU) healing (2001) (1)
T1060 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Increase the Risk of Ischemic Colitis: A Matched Case-Control Study (2010) (1)
[Boceprevir-benefit assessment by the Institute for Quality and Efficiency in Health Care (IQWiG) in accordance with Â§ 35a SGB V (dosage evaluation)]. (2012) (1)
Helicobacter pylori and esophageal neoplasia (2015) (1)
[COVID-19 from a gastroenterological perspective]. (2020) (1)
Steps forward in understanding gastric cancer risk (2022) (1)
Plasma PDGF and VEGF as sensitive biomarkers for monitoring of angiogenesis in hepatocellular cancer patients (2005) (1)
Transarterial chemoembolization (TACE) does have little impact on hepatic metabolic function in patients with hepatocelluar carcinoma (HCC). (2011) (1)
62 Safety and Success of Direct Retrograde Cholangioscopy (DRC) by Use of an Ultra-Slim Endoscope - Results of a Multicenter Study (2013) (1)
Aspects of Morphogenesis in Carcinoma of the Ampulla of Vater (1986) (1)
NMR-Based Lipid Metabolite Profiles to Predict Outcomes in Patients Undergoing Interventional Therapy for a Hepatocellular Carcinoma (HCC): A Substudy of the SORAMIC Trial (2021) (1)
579 Microscopic Barrett's Esophagus (MBE) - An Entity of Concern in the Progerd Study (2008) (1)
Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis (2021) (1)
Tu1071: COMPARATIVE EFFICACY OF ACID SUPPRESSION BACKBONES FOR HELICOBACTER PYLORI ERADICATION: RESULTS OF A NETWORK META-ANALYSIS (2022) (1)
Whipple's Disease. (2008) (1)
[Gastropexy supported single-step button gastrostomy - clinical results of a new technique for percutanous feeding tube implantation]. (2009) (1)
Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Analysis of REACH pts by Child-Pugh (CP) score. (2015) (1)
TFF3 in esophageal, gastric mucosa as well as in gastric juice (2000) (1)
The diet of Templar Knights: their secret to longevity? (2014) (1)
Su1950 - Distinct Microbiota Communities Along the Entire Human Digestive Tract (2018) (1)
[Helicobacter pylori: an infection with local complications and systemic effects]. (2011) (1)
[Therapy of acute pancreatitis]. (1997) (1)
656 Esophageal Intraluminal Baseline Impedance Differentiates Gastroesophageal Reflux Disease From Functional Heartburn in Patients With PPI Refractory Symptoms and Correlates With Morphological Changes (2013) (1)
Loss of alkaline phosphatase activity in duodenal mucosa: A marker for precursors of gastric metaplasia? (1990) (1)
Preface (2009) (1)
[Bismuth subsalicylate treatment in chronic Campylobacter pylori-associated erosive gastritis]. (1988) (1)
[Campylobacter pylori in duodenal ulcer--a concomitant phenomenon or causal association?]. (1987) (1)
Laboratory Diagnosis of Exocrine and Endocrine Dysfunctions in Inflammatory and Neoplastic Lesions (2008) (1)
Corrigendum to “Enantioselective quantification of omeprazole and its main metabolites in human serum by chiral HPLC-atmospheric pressure photoionization tandem mass spectrometry” [J. Chromatogr. B 857 (2007) 301–307] (2007) (1)
M1802 Herbal Preparation STW 5 Improved Quality of Life in Patients with Functional Dyspepsia - Results of a Placebo-Controlled Trial (2008) (1)
The role of somatostatin and octreotide in pancreatic disease : proceedings of a Symposium during the EPC Meeting, October 12, 1992, Ulm, Germany (1994) (1)
[Efficacy of a bismuth combination preparation. Efficacy in the treatment of chronic active gastritis and non-ulcerous dyspepsia]. (1990) (1)
Helicobacter pylori infection and gastric cancer in the past, current and future in Europe. (2019) (1)
W1633: Additional Yield of Histological Sampling in Patients With Suspected Small Bowel Pathology During Balloon Assisted Enteroscopy (2010) (1)
Prevalence of, and risk factors for helicobacter pylori infection in Germany (1995) (1)
Management of Helicobacter pylori-positive peptic ulcer disease. (1996) (1)
Pancreatic cancer — Endosonography (2007) (1)
[Update 2021: COVID-19 from the perspective of gastroenterology]. (2021) (1)
Helicobacter pylori Infection in Gastroesophageal Reflux Disease (1993) (1)
W1085 Functional Dyspepsia: Are Relapse Rates Influenced By Active Treatment ? (2008) (1)
Early bacterial infection of the pancreas and course of disease in cerulein-induced acute pancreatitis in rats. (2006) (1)
Spoke-Like Vascular Pattern – A Characteristic Sign of Focal Nodular Hyperplasias in the Liver (2004) (1)
The impact of high-resolution ultrasound in the differential diagnosis of non-hemolytic jaundice. (2010) (1)
The Pancreas and Aging (2003) (1)
[Sonographic study of gallbladder function: exogenous or endogenous stimulation?]. (1991) (1)
Standards and Limitations of Conservative Treatment in Chronic Pancreatitis (1996) (1)
Relationship Between Function and Morphology in Chronic Pancreatitis (1990) (1)
How do international gastric cancer prevention guidelines influence clinical practice globally? (2020) (1)
[Modern diagnostic tools for esophageal pathologies]. (2013) (1)
[Fulminant duodenal bleeding as first manifestation of a neuroendocrine carcinoma of the pancreatic head]. (2010) (1)
Inflammatory Mass in the Pancreatic Head Associated with Chronic Pancreatitis (1993) (1)
Reduced PTEN expression in gastric cancer and in the mucosa of gastric cancer relatives (2000) (1)
[The early recognition of infected fluid collections in acute pancreatitis in computed tomography]. (1994) (1)
Whipple's disease: magnification endoscopy and histological characteristics. (2008) (1)
Has education about H. pylori (Hp) infection been effective? — A worldwide survey of primary care physicians (PCPs) (2001) (1)
The Role of Surgery in Patients with Helicobacter pylori Infection (1990) (1)
1092 EFFECTS OF PRE-TREATMENT WITH BEZAFIBRATE FOLLOWED BY STANDARD OF CARE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 INFECTION AND ELEVATED GGT LEVELS (2012) (1)
Serological Diagnosis of Pancreatic Cancer (1997) (1)
Occult interferon α-induced pulmonary granulomatosis despite continuation of treatment. (2014) (1)
Acute pancreatitis after argon plasma coagulation of duodenal polyps in a patient with familial adenomatous polyposis. (2007) (1)
[Topic complex I: Definitions, epidemiology and natural course]. (2005) (1)
Usefulness of serology for diagnosis and follow-up of H.pylori infection — comparison of third vs. second generation elisa (2000) (1)
CagA status and successful eradication of Helicobacter pylori (2006) (1)
[Is sequential eradication of Helicobacter pylori effective? Sequential treatment more effective than triple therapy in patients with clarithromycin resistance]. (2013) (1)
Palliative treatment of hepatocellular cancer with octreotide, rofecoxib, or both (2003) (1)
The NERD Task Force: Overview and Consensus: Vevey, November-December 2007 (2008) (1)
553 Small Volume Acid Reflux in GERD Patients With Hiatal Hernia is Only Detectable by pH-Metry but Not by Multichannel Intraluminal Impedance (2010) (1)
[Prevention of stress-induced lesions of the gastrointestinal mucosa by means of drugs]. (1982) (1)
Impact of thoracic surgery on esophageal motor function-Evaluation by high resolution manometry. (2017) (1)
Gemcitabine plus afatinib versus gemcitabine alone in metastatic pancreatic cancer: An explorative randomized AIO phase II trial (ACCEPT). (2018) (1)
Influence of ursodeoxycholic acid on intestinal motility, pancreatic secretion and serum levels of pancreatic polypeptide and motilin (2000) (1)
Role of Acid Suppression in Exocrine Pancreatic Insufficiency: A Therapeutic Principle (2013) (1)
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib (2022) (1)
Skin-Level Gastrostomy Using a Novel Balloon-Type Device—Long-Term Results in Oncological Patients: (2001) (1)
[Prevention of stomach carcinoma by Helicobacter pylori eradication. Invitation to participate in the PRISMA Study]. (1999) (1)
Acute Infection With a CagA Positive H. pylori Strain in Healthy Subjects – Effect on Symptoms and Gastric Physiology (2011) (1)
Helicobacter pylori eradication – Author's reply (2011) (1)
Effects of pre-treatment with bezafibrate followed by standard of care in treatment-naive patients with chronic hepatitis C genotype 1 infection and elevated GGT levels (2012) (1)
[Ulcer perforation in Meckel's diverticulum]. (1984) (1)
S1994 JC Virus Is Present in H. pylori Induced Gastritis and Gastric Cancer (2008) (1)
Helicobacter pylori and GERD. Author's reply (2005) (1)
[Skin-level gastrostomy -- long-term results from a prospective trial in gastric and jejunal application]. (2004) (1)
Exocrine function and pancreatic morphology after severe acute pancreatitis (1985) (1)
How do international gastric cancer prevention guidelines influence clinical practice globally? (2020) (1)
[Long-term course of reflux symptoms following Helicobacter pylori eradication]. (2004) (1)
Effect of high dose omeprazole on urease activity in vivo (1995) (1)
Ablative Procedures for Prevention and Treatment of Esophageal Adenocarcinoma (2004) (1)
p16 protein expression in the liver: an immunohistochemical study (2008) (1)
[Is mass eradication of Helicobacter pylori infection effective for preventing gastric cancer?]. (2014) (1)
[Conservative therapy of fistulas of the anorectal area in Crohn disease]. (1999) (1)
Chapter 55A – Chronic pancreatitis: etiology, pathogenesis, and diagnosis (2012) (1)
Exocrine pancreatic secretion in man following one week of M1‐muscarinic receptor blockade (1993) (1)
[Gastric acid and parotid secretion in obesity [greater than 55%] (author's transl)]. (1981) (1)
Localized primary AL-type amyloidosis of the jejunum diagnosed by double-balloon enteroscopy. (2007) (1)
Helicobacter pylori strain variability in adhesion, cytotoxicity and il 8-release (1995) (1)
[Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview]. (2001) (1)
Gastric and Gut Microbiota in Health and Disease (2016) (1)
New developments in gastroenterology (2006) (1)
Endoscopic and Histologic Characterization of Yellow Plaques of the Small Bowel Using Double Balloon Enteroscopy (2007) (1)
[Resection of small colorectal polyps using a dedicated cold resection snare]. (2015) (1)
A Possible Role for Helicobacter pylori in the Pathogenesis of Reflux Esophagitis (1997) (1)
Age-dependent prevalence of H. pylori associated gastritis phenotypes with increased risk for gastric cancer (2003) (1)
NSAIDS and induction of erosive esophagitis (2006) (1)
Does proton pump inhibitor (PPI) pretreatment affect Helicobacter pylori (HP) sensitivity to antibiotics (1995) (1)
Significant Drop in the Serological Prevalence of Helicobacter pylori-Infection in Patients Born After 1980 in the Area of Magdeburg, Germany (2011) (1)
Helicobacter pylori eradication: the rational treatment for peptic ulcer disease--chairmen's conclusion. (1994) (1)
Small-bowel endoscopy. (2007) (1)
[Chronic pancreatitis: conservative therapy]. (1996) (1)
The Fear of Gastric Cancer in Patients with Dyspepsia: Challenge in Specialist Care Gastroenterology (2021) (1)
Sa1877 Dynamic Response of Humoral Immunity After Vaccination With a Recombinant Antigen Based Vaccine Against H. pylori in Healthy Volunteers After Infectious Challenge With H. pylori (2013) (1)
[Recurrent arterial thromboembolism in hereditary hypoplasminogenaemia]. (1996) (1)
Focus on Gastrointestinal Tumors (2013) (1)
Secretory leukocyte protease inhibitor expression in various types of gastritis – a specific role of H. pylori infection (2006) (1)
Expression of carbonic anhydrase IX protein in human pancreatic cancer (2003) (0)
M1943 Specific Increase of Lectin UEA-I Binding Proteins in the Squamous Epithelium of Patients with Barretts Esophagus (2008) (0)
HP YLORIERADICATION AND GORD: VIEWPOINT 2 Helicobacter pylori eradication does not exacerbate gastro- oesophageal reflux disease (2004) (0)
S1601 Matrix-Metalloproteases Are Involved in the H. pylori-Induced Downregulation of the Serine Protease Inhibitor SLPI in Gastric Tumor Cells (2008) (0)
T1908 Intestinal and Gastric Type Barrett's Metaplasia Differ in Their SOX-gene Expression Pattern (2009) (0)
Gastrointestinal oncology and innovative aspects in gastroenterology. Update gastroenterology 2005. Patsfraduate course 2005, Copenhagen, October 15-16 (2005) (0)
Tu1866 Expression of Proinflammatory Cytokines IL-8 and IL-1β in Erosive and Non-Erosive Reflux Disease in Comparison With Functional Heartburn (2014) (0)
[Juxtapapillary gangliocytic paraganglioma of the duodenum]. (1989) (0)
Front & Back Matter (2020) (0)
Neoplasms of the Pancreas (2004) (0)
M1918 Precise Allocation of Adenocarcinomas at the Oesophagogastric Junction is Essential for Defining the Role of H. pylori Infection in This Disease (2010) (0)
The NERD Task Force: Overview and Consensus (2016) (0)
Mo1662 The Role of SNPs of Genes Encoding Psca, MUC1 and PLCE1 in Gastritis, Gastric Cancer and Colorectal Cancer Development (2014) (0)
[Diagnosis and staging of chronic pancreatitis (I). The role of imaging methods]. (1993) (0)
The value of advanced endoscopic techniques in GERD (2007) (0)
S1054 How Often Is Crohn's Disease the Culprit of Perianal Fistulas? (2009) (0)
[Helicobacter and related species in liver and bile ducts: pathogenic agents of harmless saprophytes]. (1999) (0)
Sa1098 Preneoplastic Conditions Are Frequent in Patients With Gastric Ulcer (2015) (0)
M1979 Dkk-2, a Modulator of Wnt-Signaling Pathway, Is Specifically Induced in Gastric Cancer Independent of the Histological Type (2009) (0)
Subject Index Vol. 21, 2003 (2004) (0)
Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial (2019) (0)
Validation of Hepa-index as a non-invasive biomarkers panel for assessment of hepatic fibrosis in Egyptians with chronic hepatitis C (2017) (0)
[Helicobacter pylori infection: a facilitator of stomach cancer?]. (1991) (0)
Evolution of GERD over 5 years: author’s reply (2012) (0)
Helicobacter pylori in peptic ulcer disease : proceedings of a Symposium held in Brussels, Belgium, 23 September 1993 (1994) (0)
T1970 The Desmosomal Proteins Desmoglein and Plakoglobin Are Up Regulated in Patients with Both Non-Erosive and Erosive Gastroesophageal Reflux As Compared to Controls (2008) (0)
Protein expression of tumor suppressor gene p16 in gastric cancer (2001) (0)
M1141 Diagnostic Accuracy of Serum Pepsinogens and Gastrin to Follow-up Helicobacter pylori Infection: A Pilot Study (2010) (0)
New Developments in the Management of Gastric Cancer (2005) (0)
Sorafenib therapy in patients with advanced hepatocellular carcinoma in liver cirrhosis: a single center experience (2010) (0)
Helicobacter pylori infection, premalignant gastric lesions and gastric cancer in the Baltic States: a review (2011) (0)
Retraction Statement. Paper by Krznarić Ž, Vranešić Bender D, Kunović A, Kekez D, Štimac D: Digestive Diseases 2012;30:196-200 (DOI: 10.1159/000336965) (2014) (0)
Cyclooxygenase expression and mucosal PGE2 levels under the influx of low-dose aspirin and Helicobacter pylori (2005) (0)
Tu1930 Novel Prognostic Biomarkers in Patients With Hepatocellular Carcinoma (2015) (0)
Non-invasive assessment of Crohn's disease complications by High end ultrasound with SonoCT® and Harmonic Imaging – A new diagnostic approach with a high accuracy (2011) (0)
Mo1675 Learning Curve of Direct PerOral Cholangioscopy Using Ultra Slim Gastroscopes (2013) (0)
Contents Vol. 26, 2008 (2009) (0)
Mo1203 The Resection of Small Colorectal Polyps With a New Cold Resection Snare Is Safe and Highly Effective (2015) (0)
Contents vol. 36 (2018) (0)
Acknowledgement to Referees (2015) (0)
Eosinophile Ösophagitis: Ein Progressreport (2004) (0)
Front & Back Matter (2021) (0)
[Adaptation of the pancreas following resection of the small intestine influenced by gastrointestinal hormones]. (1989) (0)
Effect of procain-HCL on phospholipase A2 in experimental acute pancreatitis in rats (2000) (0)
Editorial: Helicobacter pylori infection: pathogenesis, antibiotic resistance, advances and therapy, new treatment strategies (2022) (0)
Front & Back Matter (2017) (0)
Solubility Characteristics of Different Bismuth Salts in Gastric Juice (1993) (0)
Front & Back Matter (2019) (0)
P722 PERFORMANCE AND VALUE OF IFN-LAMBDA3 AND IFN-LAMBDA4 GENOTYPING IN PATIENTS WITH CHRONIC HEPATITIS C (CHC) GENOTYPE 2/3 IN A REAL WORLD SETTING (2014) (0)
Gastric Cancer in Autoimmune Gastritis: A Case–Control Study from the Star Project on Gastric Cancer Research (2017) (0)
Front & Back Matter (2014) (0)
Effect of Helicobacter pylori infection on epidermal growth factor receptor (EGFR) expression and cell proliferation of gastric epithelial mucosa (2001) (0)
T1083 In Search for a Healthy Stomach and Esophagus – Does Endoscopy Add to Careful Symptom Evaluation in Asymptomatic Individuals? (2010) (0)
Mo1921 PAR2-Mediated IL-8 Secretion by Esophageal Cells Is Dependent From Repeated Stimulation With Acidic pH. a 2-Step Model of Mucosal Immune Response in the Pathogenesis of Gastro-Esophageal Reflux Disease (2015) (0)
Front & Back Matter (2017) (0)
146 Identification of novel tumour-associated autoantibody signatures in gastric cancer (2010) (0)
Front & Back Matter (2020) (0)
Introduction (1998) (0)
Increased beta-catenin expression in gastric cancer: Correlation with APC gene mutation (2000) (0)
H. pylori infection: Clinical management from a European perspective (2003) (0)
[Libyan patient with chronic diarrhea]. (1996) (0)
Subject Index Vol. 11, 1994 (1994) (0)
Editorial (2002) (0)
Editorial (2001) (0)
CHRONISCHE PANKREATITIS : KONSERVATIVE THERAPIE (1996) (0)
Editorial (2005) (0)
Session 4: Long-term medical management (2001) (0)
Editorial (2015) (0)
[Diagnosis and staging of chronic pancreatitis (II). The role of functional tests]. (1993) (0)
Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial (2022) (0)
Preliminary Pages / Contents / Preface (2003) (0)
Su1629 Evaluation of a New Biomechanical Stent Design for the Treatment of Benign Biliary Strictures in Patients With Chronic Pancreatitis - First Clinical Results (2014) (0)
Helicobacter pylori Infection. (2019) (0)
Dual role of serum soluble E-cadherin as an indicator of metastatic development in gastric cancer (2003) (0)
Images of interest. Gastrointestinal: sonographic features of celiac disease. (2004) (0)
Molecular Aspects of Hepatocellular Carcinoma (2018) (0)
Letter: bismuth quadruple therapy with Pylera for Helicobacter pylori infection – authors’ reply (2014) (0)
What causes discrepancies between the endoscopic and histological diagnosis of Barrett's epithelium? A report from the progerd study initiative (2003) (0)
[German Academy for Microtherapy ("DAfMT") - modern, image-guided, minimally invasive, microtherapeutic, partially interdisciplinary approaches to treatment for clinical education and practice]. (2011) (0)
Evaluation of the 13C-mixed triglyceride breath test for exocrine pancreatic insufficiency (1998) (0)
Front & Back Matter (2018) (0)
Presentations at Gastro Update Europe 2018, Prague (2018) (0)
Contents Vol. 29 (2011) (0)
Contents Vol. 83, 2011 (2011) (0)
W1849 Clinical Course of Extra-Esophageal Disorders in Gastroesophageal Reflux Disease During Routine Care: A 5-Year Follow-Up Study (2009) (0)
523 The Gene Expression of PAR-2 and TRPV-1 Is Increased in Erosive and Non-Erosive GERD (2008) (0)
Biomarkers for Diagnosis and Surveillance in Hepatocellular Carcinoma (2012) (0)
Mucosal expression of the fragile histidine triad in gastric carcinoma in relation to type, grade and stage of tumour (2001) (0)
Tu1105 Management of Patients With Gastroesophageal Reflux Disease (GERD) in Germany - A Survey Among Gastroenterologists (2015) (0)
Helicobacter pylori and inflammation : satellite symposium to the X international workshop on gastroduodental pathology and helicobacter pylori, 13 September 1997, Lisbon, Portugal (1998) (0)
Contents Vol. 40, 2022 (2022) (0)
Gut Microbiota: The Forgotten Organ: EAGE Postgraduate Course, Sorrento, March 2011 (2011) (0)
Contents Vol. 29 (2011) (0)
Functional Heartburn, Functional Heartburn, Nonerosive Reflux Disease, Nonerosive Reflux Disease, and Reflux Esophagitis Are All Distinct and Reflux Esophagitis Are All Distinct Conditions—A Debate: Con Conditions—A Debate: Con (2007) (0)
T1964 Dilation of Intercellular Spaces in Esophageal Epithelium in Non-Erosive and Erosive Reflux Disease Patients and Appropriate Controls (2008) (0)
The freedom of choice. (2017) (0)
Su1521 Esophageal “Outlet Patches”: Endoscopic, Histologic and Electronmicroscopic Description of New Lesions (Small Vesicles Containing Gastric Metaplasia and Submucosal Glands) At the Gastroesoophageal Jucntion (2013) (0)
Medical and Surgical Conditions for the Treatment of Malabsorption (2014) (0)
Complete Contents Vol. 17, 2001 (2001) (0)
Helicobacter pylori infection : new facts, new views (2001) (0)
Prevalence of Helicobacter pylori infection, intestinal metaplasia and atrophy in gastric cancer of different clinical stages (1998) (0)
[Standards of laboratory diagnosis of acute pancreatitis]. (1991) (0)
[Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)]. (2009) (0)
[Calcification of gallbladder wall]. (2005) (0)
Management of Portal Hypertension – Digestive Diseases (2005) (0)
[Changes in trends and fashions in the upper gastrointestinal tract: focus on the esophagus]. (2003) (0)
Hepatobiliary and pancreatic: Multiple hepatic adenomas (2007) (0)
Tu2054 Siewert Type Does Not Reflect Cancer Biology at the Gastro-Esophageal Junction (2016) (0)
Diffuse oesophageal spasm. (2007) (0)
Liver Cell Cancer (2002) (0)
Cathepsin G and Protease-Activated Receptor-4 (PAR-4) in Mucosal Inflammation of Gastroesophageal Reflux Disease (GERD) (2011) (0)
Front & Back Matter (2018) (0)
S16.4: Disease-related costs in patients with Gastroesophageal Reflux disease by routine care (2004) (0)
H. pylori infection impairs the anaerobic threshold in well trained athletes (2000) (0)
Loss o f B eta-Catenin E xpression i n M etastatic G astric C ancer (2003) (0)
[Helicobacter pylori infections: current evaluation of their relevance]. (1999) (0)
Sa247 NEW ACCURATE HELICOBACTER PYLORI RAPID BLOOD TEST BASED ON COMBINED FLID AND CAGA ANTIBODIES (2021) (0)
Su1914 Significant Differences Between the Microbiota Profiles of Luminal and Mucosal Samples of the Upper GI-Tract As Revealed by rRNA- Sequencing (2016) (0)
Metabolic and Autoimmune Diseases of the Digestive System: EAGE Postgraduate Courses, Opatija/Prag, April/May 2011: Selected Articles (2012) (0)
[Peptic ulcer disease. Clinical evaluation in 2006]. (2006) (0)
[Relations between gastrointestinal interdigestive motility and secretion]. (1991) (0)
Su1115: COMPARISON OF FIVE HELICOBACTER PYLORI POINT- OF- CARE- TESTS (POCT) (2022) (0)
Correlation with direct peroral cholangioscopy in a patient with papillary cholangiocarcinoma Running title : Virtual (2016) (0)
Is Helicobacter pylori orally transmitted in school children around puberty (1997) (0)
M1917 CCKB-Receptor is Downregulated in Gastric Cancer Independent From Tumor Localisation (2010) (0)
[Helicobacter pylori: screen and treat?]. (2014) (0)
Gastroesophageal reflux. Foreword. (2009) (0)
Contents Vol. 6, 2019 (2019) (0)
Innovations in interventional endoscopy. Introduction. (2008) (0)
Differential expression of microRNAs in preneoplastic gastric mucosa AlexanderLink,WiebkeSchirrmeister, CosimaLangner,MariyaVarbanova, JanBornschein,ThomasWex (2015) (0)
W1895 Helicobacter pylori Infection, Gastric Atrophy and the Risk for Oesophageal Squamous Cell Carcinoma in Germany (2009) (0)
Su1986 Epithelial Proliferation/Apoptosis Balance in Atrophic Gastritis in Presence and Absence of Gastric Cancer: A Molecular/ Immunohistochemical Evaluation (2013) (0)
Acute Biliary Pancreatitis (1990) (0)
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression (2022) (0)
Su1983 Pepsinogen I/II Ratio Is Superior to Pepsinogen I and II and Gastrin 17 in the Diagnosis of Atrophic Gastritis (2013) (0)
[Drug treatment of gastroesophageal reflux disease]. (2003) (0)
The long-term effect of Helicobacter pylori eradication on the expression levels of COX-1 and -2, 5-LOX and leukotriene-receptors in human gastric mucosa (2007) (0)
Contents Vol. 6, 2019 (2019) (0)
Front & Back Matter (2016) (0)
Preface (2016) (0)
The influence of gastric atrophy on Helicobacter pylori antibiotics resistance in therapy-naïve patients (2022) (0)
Impact of aspirin and comedications on healing of biopsy-induced erosions (2006) (0)
Bismuth and Helicobacter pylori (1994) (0)
[Effect of thyrotropin releasing hormone and histidyl-proline diketopiperazine on enzyme section of isolated pancreatic acinar cells of the rat]. (1994) (0)
Sa1877 Methylation of miR-137 Is a Frequent and Early Event in Gastric Carcinogenesis (2014) (0)
Preface (2011) (0)
Controversies in Gastrointestinal Diseases: 8th European Bridging Meeting in Gastroenterology, EAGE Postgraduate Course, Naples, November 2006 (2007) (0)
721 Impact of diet and pioglitazone for treatment of NAFLD (2006) (0)
Sa1985 Leukotriene B4 Receptor-1 (Blt-1) and Cysteinyl Leukotriene Receptor-2 (Cyslt-2) Are Deregulated in Both Transformed and Non-Transformed Epithelium of Patients With Esophageal Squamous Cell Carcinoma (2013) (0)
Front & Back Matter (2017) (0)
Front & Back Matter (2020) (0)
[Helicobacter pylori infection and non-ulcer dyspepsia]. (1995) (0)
Tu1865 Neuroinflammatory Changes in the Esophageal Mucosa of Patients With Functional Heartburn When Compared With Gastroesophageal Reflux Disease (2014) (0)
GERD – Evolving and Expanding (2004) (0)
TNF-alpha is a key factor in the pathogenesis of gastroduodenal damage induced by low-dose aspirin and Helicobacter pylori infection (2003) (0)
Helicobacter pylori Infection: To Eradicate or Not to Eradicate (2009) (0)
Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma (2021) (0)
Circulating trypsin (2005) (0)
Title Page / Table of Contents (2004) (0)
Expression of trefoil peptide-1, -2 and -3 in various stages of gastric carcinogenesis (2001) (0)
M1695 Serum Pepsinogens and Topography of Chronic Atrophic Gastritis in a Population Sample Referred for Endoscopy (2010) (0)
Author Index and Subject Index (2001) (0)
Subject Index Vol. 67, 2003 (2003) (0)
Author Index and Subject Index (2001) (0)
M1829 Chronic Inflammation of the Cardia in Gastroesophageal Reflux Disease (GERD) Is Not Regulated By FOXP3 Expressing Regulatory T Cells (2009) (0)
Clinical Presentation and Course of Chronic Pancreatitis (1997) (0)
Is the sex-related impairment of the anorectal sphincter consequent to diminished rectal sensitivity? (2000) (0)
[Ulcerative disease and dyspepsia--which treatment is proven?]. (2001) (0)
Subject Index Vol. 71, 2005 (2005) (0)
Tu1101 Prevalence of Gastric atrophy and Intestinal Metaplasia Among Patients With Gastric and Duodenal Ulcers in Saxony-Anhalt, a Region at Increased Risk for Gastric Cancer (2016) (0)
Front & Back Matter (2021) (0)
[What therapy is meaningful in chronic hepatitis C and resection of hepatocellular carcinoma for recurrence prophylaxis?]. (2002) (0)
Editorial (2001) (0)
Comprar Regulation of Medical Products | M. W. Buechler | 9780727917805 | Wiley (2009) (0)
[Epidemiology and pathogenesis of Helicobacter pylori infection]. (2002) (0)
Mo1200 Blue Light Imaging and Linked Color Imaging for Detection and Characterization of Chronic Gastritis (2017) (0)
14 Endoscopic Ultrasound in the Diagnosis of Chronic Pancreatitis and Pancreatic Cancer (2004) (0)
Contents Vol. 22, 2004 (2005) (0)
Th17 Immune Response in H. Pylori Infection ex vivo and in vitro (2017) (0)
Interim Analysis of Overall Survival Per Subgroups in the Prospective, Non-Interventional Insight Study in Patients with Hepatocellular Carcinoma Treated with Sorafenib (2012) (0)
Contents Vol. 22, 2004 (2005) (0)
Management of Portal Hypertension (2005) (0)
The Role of Helicobacter Pylori in Barrett's Esophagus (2007) (0)
Alteration of fibroblast growth factor expression following acute pancreatitis (1998) (0)
Severe cases of sprue‐like enteropathy associated with angiotensin receptor blockers other than olmesartan (2021) (0)
[Synthesis of glycoproteins by mucosa of gastric antrum in chronic gastritis B]. (1994) (0)
The gastritis phenotype in gastric ulcer (GU) is not corpus predominant. Observations from the byk advanced gastric ulcer study (BAGUS) before and after eradication (2001) (0)
Mo1679 Direct PerOral Cholangioscopy Using Ultra Slim Gastroscopes - Technical Feasibility and Diagnostic Yield (2013) (0)
Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib – results from a non-interventional multi-center study (2020) (0)
Tu1139 Gastroesophageal Reflux Diseases is Associated With an Upregulation of Desmosomal Proteins (Desmogleins-1, −2, −3, Plakoglobin) in Cardia Mucosa (2012) (0)
Contents Vol. 20, 2002 (2002) (0)
Hepatocellular cancer (HCC) contributes in a significant way to the worldwide burden of neoplastic diseases.. Preface. (2009) (0)
The Expression of Angiotensin Converting Enzyme (ACE) in Tumor Cells may Increase Invasive Ability and Promote Lymph Node Metastases (2005) (0)
Autoantibodies to glycoprotein 2 are associated with the clinical phenotype in Crohn's disease (2014) (0)
Gastrointestinal disorders are among the most common disorders encountered in the United States and Europe. (2004) (0)
Role of Helicobacter pylori in Gastroesophageal Reflux Disease (2012) (0)
Therapeutic Approach in Functional (Nonulcer) Dyspepsia (2011) (0)
TRH-immunoreactivity in chronic pancreatitis. (1992) (0)
Imatinib for hepatocellular cancer (HCC)-Focus on PK/PD modelling and liver function. (2006) (0)
Su1828 MiR-155 Expression in Helicobacter pylori Infection, Inflammatory and Precancerous Gastric Conditions (2015) (0)
Introduction (2007) (0)
Angiotensin II Receptor Blockers And Intestinal Malabsorption: An Observational Cohort Study In Germany And Italy (2017) (0)
50th Anniversary of the EAGEN (2020) (0)
[Visceral medicine 2011 - Interdisciplinarily on the road to continuous progress]. (2011) (0)
Pancreatectomy: Preoperative risk evaluation of the pancreatico-intestinal anastomosis (1996) (0)
Challenges in Inflammatory, Preneoplastic and Neoplastic Diseases of the Digestive System (2014) (0)
Young GI Angle: My best career decision (2019) (0)
Images of interest. Hepatobiliary and pancreatic: Pancreatic metastases. (2004) (0)
A Fresh Look at Autoantibodies in Chronic Pancreatitis (1990) (0)
H. pylori infection is related to visceral hypersensitivity in patients with irritabile bowel syndrom (IBS) (2000) (0)
Contents Volume 4, 2017 (2018) (0)
Acid Inhibition and Peptic Ulcer - 100 Years of Carl Schwarzs Dictum: No Acid - No Ulcer: EAGE Postgraduate Course, Zagreb, November 2010 (2011) (0)
Twelve month endoskopic and histological analysis followingproton-pump inhibitor-based tripple therap, in Helicobacterpositive patients with gastric ulcer (2010) (0)
Contents Volume 4, 2017 (2018) (0)
Front & Back Matter (2013) (0)
[Short guideline for the management of dyspepsia]. (2004) (0)
[Protease inhibition and pancreatic adaptation]. (1989) (0)
Sections Vol. 67, 2003 (2003) (0)
General and Specific Prevention Strategies for Gastrointestinal Cancers (2016) (0)
Pre- and post-endoscopy pepsinogen I in serum (2000) (0)
Commentary: biopsy to diagnose GERD – better, but not yet a stand‐alone test; authors' reply (2013) (0)
Letter to the editor: Helicobacter pylori eradication – the proof is not in the symptoms (2022) (0)
Mo1585 Dkk-2, a Modulator of Wnt-Signaling Pathway, is Overexpressed in Gastric Cancer (2012) (0)
T1979 Pepsinogen II As Marker of Inflammation in H.P Infection and in NSAIDs Damage (2009) (0)
T1129 Escalating Dose of Esomeprazole for Symptom Relief is Rarely Required in Properly Selected Patients With GERD – A Monocentric Study Based on 48 Hours BRAVO pH Metry (2010) (0)
[Helicobacter pylori--a pathogen with many faces]. (1991) (0)
Gastric emptying in swine: Non-invasive radiologic assessment without anaesthesia? (2000) (0)
S1867 A Novel Eosinophilic Esophagtis Score (EES) Allows to Predict Eosinophilic Esophagits in Adults (2009) (0)
Prelims (2020) (0)
[Helicobacter pylori-New aspects of forthcoming guidelines]. (2022) (0)
Subject Index Vol. 17, 2001 (2001) (0)
Predicting the placebo response in a clinical trial based on pre-trial data (2008) (0)
Sa1963 Identification of Individuals at Risk for Gastric Cancer Who Undergo Screening Colonoscopy (2015) (0)
Mo1593: GUT BACTERIA FUNCTIONALITY PROFILES AND DIVERSITY INDEX VARIATIONS IN PATIENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS (2022) (0)
Mucosal expression of CDK cell cycle activators in patients with H. pylori-positive or H. pylori-negative chronic gastritis (2001) (0)
Prevention and Progress in Management of Gastrointestinal Cancers (2002) (0)
Helicobacter pylori infection: diagnosis, treatment and risks of untreated infection (2008) (0)
Editorial (2007) (0)
Role of infection in gastroduodenal pathology. (1988) (0)
Subject Index Vol. 26, 2008 (2009) (0)
DNA methylation in human gastric epithelial cells defines regional identity without restricting lineage plasticity (2022) (0)
Front & Back Matter (2018) (0)
Eligibility of patients with hepatocellular carcinoma for systemic treatment with sorafenib. (2009) (0)
AUTOANTIBODIES TO GP2-A NEW MARKER FOR CROHN'S DISEASE (2011) (0)
Influence of Laboratory and Clinical Factors on the Assessment of Gastric Serum Parameters (2017) (0)
State of the Art Lecture: Maastricht-3 2005--The management of H. pylori infection now and future〔含英文〕 (特集第10回JAPANGAST Study Groupハイライト) (2006) (0)
[Successful control of iatrogenic bleeding after endoscopic papillotomy by means of supraselective microcatheterisation and coiling in a patient with a suspicious tumour mass at the pancreatic head and atypical arteriohepatic perfusion (Michels Type IV)]. (2012) (0)
Mo1547 Racgap1 is Involved in Wnt-Dependent Signalling in Gastric Adenocarcinoma (2012) (0)
A Global Perspective on Gastric Cancer Screening: Which Concepts Are Feasible, and When? (2023) (0)
Cardia-type mucosa is the predominant type of metaplasia in columnar lined lower esophagus (2003) (0)
Su1979 Adenocarcinomas at the Esophagogastric Junction At the Most Distal Location (Siewert Type 3) are More Likely Associated With Preneoplastic Mucosal Changes in the Stomach Than Proximal Tumors (2014) (0)
Peptic ulcer disease: further work is required to reduce inequalities – Authors' reply (2010) (0)
S1388 Vonoprazan-based Dual Therapy and Vonoprazan-based Triple Therapy for H. pylori Eradication: A Comparison of the Available Data (2021) (0)
Introduction (2008) (0)
[Ultrastructural aspects of active and healed duodenal ulcer]. (1987) (0)
Sa1086: LONG NON-CODING RNA HOTAIR EXPRESSION IN GASTRIC CANCER AND PRENEOPLASTIC CONDITIONS (2022) (0)
Subject Index Vol. 20, 2002 (2003) (0)
[Relation of interdigestive gastrointestinal motility and pancreas-bile secretion]. (1989) (0)
Interdigestive relationship between gallbladder and gastroduodenal motility and bile salt secretion (1995) (0)
Front & Back Matter (2017) (0)
Determination of Helicobacter pylori cagA, vacA genotypes with real-time PCR in gastric biopsy specimen. Correlation to proliferation immunhistochemical data (2001) (0)
Multistep approach for treatment of non-alcoholic fatty liver disease – the impact of diet and pioglitazone (2006) (0)
The active bacterial assemblages of the upper gastrointestinal tract in individuals with and without Helicobacter infection (2017) (0)
Sa1376 Systemic Immunologic Response to H. pylori CagA Is Modulated by Bacterial vacA Genotypes (2016) (0)
W1393 Is Tumor M2-Pyruvate Kinase (PK) a Potential Marker for the Discrimination Between Chronic Pancreatitis and Pancreatic Cancer? (2008) (0)
The pH-Hp challenge : from mechanism to management : proceedings of a symposium held in Copenhagen, Denmark, 29 April 1995 (1996) (0)
[Early gastric cancer--diagnosis and therapy]. (2006) (0)
[Gastrointestinal innovations]. (2018) (0)
' s response to reviews Title : High efficacy in Helicobacter pylori retreatment : seven days with furazolidone , levofloxacin and lansoprazole , in Sao Paulo , Brazil (2009) (0)
Contents Vol. 2, 2015 (2016) (0)
S1214 Malignant Small Bowel Tumors in Patients Undergoing Double-Balloon Enteroscopy (DBE) for Obscure Gastrointestinal Bleeding (OGIB) (2009) (0)
Reply to Gonen et al. (2009) (0)
Editorial (2004) (0)
Contents Vol. 80, 2009 (2009) (0)
Chapter 57 – Etiology, pathogenesis, and diagnosis of chronic pancreatitis (2017) (0)
W1734 A New Role of Alpha 1-Antitrypsin/Alpha-1 Peptidase Inhibitor (A1-PI) in Gastroduodenal Diseases (2008) (0)
952 Active Gastric Inflammation in Human Volunteers After Exposure to a Cag-Positive H. pylori Challenge in a Placebo Controlled Vaccine Trial (2016) (0)
Implementing a novel method to estimate the "Burden of Therapy" (BOTh) for patients with metastatic pancreatic cancer treated with gemcitabine plus afatinib vs. gemcitabine in the AIO ACCEPT trial. (2020) (0)
[Helicobacter pylori infection, gastritis and non-ulcer dyspepsia--is there a connection?]. (1991) (0)
Front & Back Matter (2018) (0)
[Helicobacter pylori does not prevent asthma"]. (2008) (0)
Pancreatic Cancer - An Update (2001) (0)
[Helicobacter pylori--diagnosis and treatment]. (2011) (0)
Tu1140 The Combined Presence of Gastroesophageal Reflux Disease and H. pylori Leads to Reduced Mucosal Inflammation in the Cardia Mucosa (2012) (0)
Front & Back Matter (2020) (0)
BALAD-2 score for the prediction of survival in patients with hepatocellular carcinoma. (2014) (0)
Gastroesophageal reflux disease (GERD) and its management in pregnancy – A prospective cohort study (2008) (0)
[Functional relation of the stomach and pancreas]. (1989) (0)
Effects of Somatostatin and Octreotide on Pancreatic Function (1993) (0)
Sa1137 Changing Trends in the Aetiology of Peptic Ulcer Disease in a Tertiary Hospital of Germany (2014) (0)
Interventional Endoscopy and Laparoscopy in GI Diseases (2005) (0)
M1815 A Microscopic Esophagitis Is the Basic Underlying Condition in Non-Erosive Reflux Disease (NERD) (2009) (0)
Front & Back Matter (2021) (0)
Palliative treatment of unresectable pancreatico-biliary cancer by either Gemcitabine or Octreotide/Imatinib – impact on biomarkers of angiogenesis (2007) (0)
Sa1860 Serum Pepsinogens for Detection of Fundic Gastric Atrophy in Subjects With Autoimmune Thyroid Disease (2014) (0)
Induction of TFF-1 in the pancreas over-expressing transforming growth factor-alpha (1998) (0)
T1082 Eradication Rate of Helicobacter pylori in Immigrant Patients Compared to Italian Patients: Results of a Clinical Trial (2010) (0)
Identification by differential display of metallothionein-II, a gene differentially expressed in gastric cancer (1998) (0)
Reply to: "Toxicity and dosimetry in SORAMIC study": Y90 radioembolization is less about tumor dose, but preserving liver function: SIRT should mimic selective techniques as employed in TACE. (2020) (0)
Standards and Innovations in Gastrointestinal Endoscopy (2003) (0)
[Histological and ultrastructural findings in the healing phase of duodenal ulcer]. (1985) (0)
Ursodeoxycholic acid (UDCA) inhibits interdigestive duodenal and gallbladder motility, pancreatic secretion and hormone release in man (1995) (0)
Contents Vol. 71, 2005 (2005) (0)
Front & Back Matter (2020) (0)
[Treatment of severe chronic constipation: differential roles of conventional laxatives and the prucalopride prokinetic]. (2011) (0)
Impact of non-alcoholic fatty liver disease for hepatocellular cancer (2003) (0)
Letter: multivariate clinical model for eosinophilic oesophagitis – is this generalisable to a general population? Authors’ reply (2017) (0)
Distinct inhibitory role of Helicobacter pylori for the expression of the secretory leukocyte protease inhibitor in the stomach and duodenum (2003) (0)
73 Epigenetic Silencing of Dll1 Regulates Notch Activation in Gastric Cancer (2008) (0)
Editorial (2003) (0)
Introduction (2009) (0)
S1659 H. pylori-Infection Changes Proepithelin Levels in AGS Cells Independent of the Expression of Secretory Leukocyte Protease Inhibitor (SLPI) (2010) (0)
M1820 Gastroesophageal Reflux Disease Is Associated with Molecular Changes in the Architecture of Desmosomes in the Esophageal Mucosa (2009) (0)
[Splenic metastases in pseudomyxoma peritonei]. (2004) (0)
Debate: endoscopy is unnecessary in the management of uncomplicated GERD. (2006) (0)
Front & Back Matter (2019) (0)
[Alcoholic pancreatitis]. (1981) (0)
[Prevention of gastrointestinal cancer]. (2021) (0)
Professional, Legal and Ethical Challenges in Gastroenterology (2007) (0)
Helicobacter pylori in Peptic Ulcer Disease: Chairmen's Introduction (1994) (0)
Diagnostic, Clinical and Therapeutic Impact of Double-Balloon Enteroscopy (2006) (0)
Evolving clinical evidence for selective internal radiation therapy in hepatocellular carcinoma (2012) (0)
Tu1069: GLOBAL TEMPORAL TRENDS IN THE EFFICACY OF CLARITHROMYCIN-CONTAINING REGIMENS IN HELICOBACTER PYLORI ERADICATION (2022) (0)
Contents Vol. 67, 2003 (2003) (0)
Heartburn-like symptoms are not only induced by abnormal gastro-esophageal reflux, but also associated with impaired gastric motility (2000) (0)
The Year in Helicobacter 2007 (2007) (0)
Subject Index Vol. 77, 2008 (2008) (0)
M1849 Zonulin Is Not Increased in the Cardia and Esophageal Mucosa of Patients with Gastroesophageal Reflux Disease (2009) (0)
Tu1443 New Generation Flexible Spectral Imaging Color Enhancement Is Useful to Predict Histology of Small Colorectal Polyps (2014) (0)
[Relation of the stomach and pancreas in the human]. (1989) (0)
Molecular Medicine in Gastrointestinal Oncology: EAGE Postgraduate Course, Budapest, May 2011 (2012) (0)
[Helicobacter pylori infection--current status in clinical practice and prospects]. (2002) (0)
Midgut Bleeding: The Concept of Emergency Double Balloon Enteroscopy (DBE) (2009) (0)
P154 Intestinal Immune-Modulation by Enteric Glia Involves Signaling Via Nod Receptor and Nuclear FACTOR-kappaB IN RAT (2007) (0)
Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps (2019) (0)
Digestive diseases. Preface. (2011) (0)
Contents Vol. 84, 2011 (2011) (0)
Tenofovir disoproxil fumarate in severe acute hepatitis B (2008) (0)
Small-bowel endoscopy. (2009) (0)
Antiangiogenis vs. chemotherapy: Impact upon biomarkers in advanced hepatocellular cancer (HCC) (2007) (0)
Su1974 Autoimmune Gastritis in Subjects With Autoimmune Thyroid Disease (2015) (0)
Prognostic factors associated with treatment response to octreotide in advanced hepatocellular cancer (HCC) (2004) (0)
Subject Index Vol. 83, 2011 (2011) (0)
S1531: Diagnostic Quality of Adenomatous Polyps Resected by Snare Polypectomy: Does the Utilization of a Submucosal Cushion Improve Their Histological Evaluation? (2010) (0)
S1379: Colonic Perforations: How Feasible and Effective Is Immediate Endoscopic Closure? (2010) (0)
Gastroesophageal Reflux Disease: EAGE Postgraduate Course, Budapest, September 2008 (2009) (0)
Differential expression of caveolin-1 in gastric cancer cells and adjacent stromal tissue (2003) (0)
Tu1072: COMPARATIVE EFFICACY OF HELICOBACTER PYLORI ERADICATION THERAPIES: A NETWORK META-ANALYSIS (2022) (0)
Subject Index Vol. 80, 2009 (2009) (0)
[Campylobacter pylori--is there a connection with peptic ulcer?]. (1987) (0)
An uncommon cause of epigastric pain and emesis. (2012) (0)
From Chronic Inflammation to Cancer: Falk Symposium 173, Brno, June 2010 (2010) (0)
Inverse correlation of LAR and beta-catenin expression in intestinal type gastric cancer (2001) (0)
783 H. pylori Infection Is As Important in Proximal As in Distal Gastric Cancer (2009) (0)
Doppelballonenteroskopie zur Evaluation der Malabsorption (2008) (0)
Double-Balloon Enteroscopy (DBE) Assisted Chromoendoscopy of the Small Bowel in Patients with Familial Adenomatous Polyposis (FAP) Syndrome (2006) (0)
[Current diagnostic methods for detection of Helicobacter pylori infection]. (2001) (0)
Comparison of different methods for determination of pepsinogen I as a marker of gastric atrophy — Can ELISA replace RIA? (2000) (0)
Dynamics of Acute H. Pylori Infection Based on Non Invasive Testing Following Challenge with a CAG+A-Positive Strain (2017) (0)
Treatment of Helicobacter pylori Reinfection (1999) (0)
Eradication of H.pylori infection: a promising strategy in the prevention of gastric cancer (2009) (0)
Panel Discussion (1973) (0)
Development and External Validation of the Munich Sorafenib Evaluation Score for Hepatocellular Carcinoma (2022) (0)
[Treatment of H. pylori infection--always necessary--pro]. (2004) (0)
Reply to S. Rana (2008) (0)
Author and Subject Index (2004) (0)
Cardia-type metaplasia occurs regularly following distal esophageal resection (2003) (0)
Tu1561: GUT MICROBIAL SIMILARITY IN TWINS IS PREDOMINANTLY DETERMINED BY SHARED ENVIRONMENT AND AGING (2022) (0)
Left sided thoracic compression through an accidental fall. (2011) (0)
Preliminary Pages / Table of Contents / Abbreviations / Preface (2004) (0)
Tu1855 Expression of Cathepsin-G and Protease Activated Receptor-4 in Erosive and Non-Erosive Reflux Disease in Comparison With Functional Heartburn and Controls (2013) (0)
High End Ultrasound With Sonoct® and Harmonic Imaging – A New Diagnostic Modality With a High Accuracy in Crohns Disease Complications (2011) (0)
Band 17, Heft 4, December 2001 (2001) (0)
Author and Subject Index (2004) (0)
Editorial (2004) (0)
Subject Index Vol. 22, 2004 (2005) (0)
Effect of the acute administration of ursodeoxycholic acid on postprandial antroduodenal and gallbladder motility, pancreatic secretion and PP release in man (1995) (0)
Is Standard Triple Therapy for H.pylori Failing in Asia?: 127 (2014) (0)
Subject Index Vol. 78, 2008 (2009) (0)
Non-invasive assessment of Crohn's disease complications by High Resolution Ultrasound (2009) (0)
Subject Index Vol. 22, 2004 (2005) (0)
Differential expression of caveolin-1 in gastric cancer cells and adjacent non-epithelial tissue (2004) (0)
CDC25A and CDC25B phosphatases as targets of c-myc in human gastric cancer (2001) (0)
Budesonide in autoimmune liver disease (2004) (0)
S1649 Activation of Proteinase Activated Receptor-2 (PAR-2) and IL-8 Release in H. pylori-Infected Patients (2010) (0)
Foreword (2009) (0)
Outcomes research for prognostic scores in hepatocellular cancer (HCC): Can we do any better? (2015) (0)
Helicobacter: Past, Present and Future 20th Anniversary of the European Helicobacter Study Group (2007) (0)
[Acute pancreatitis: new diagnostic possibilities]. (1988) (0)
Predominantly Expressed in NK Cells, Is Human Cathepsin W, a Cysteine Protease (2001) (0)
Author ' s response to reviews Title : Promoter methylation of CDKN 2 A and the lack of p 16 expression characterize patients with hepatocellular carcinoma (2009) (0)
Front & Back Matter (2016) (0)
Front & Back Matter (2019) (0)
[Diagnosis and therapy of Helicobacter pylori infection. Guidelines of the German Society of Digestive and Metabolic Diseases. Working Group of the German Society of Digestive and Metabolic Diseases]. (1996) (0)
Contents Vol. 5, 2018 (2019) (0)
The Number of Lymph Node Metastases in Gastric Cancer correlates with the Angiotensin II-receptor 1 (AT1R) (2005) (0)
Contents Vol. 5, 2018 (2019) (0)
The Intriguing Relationship of Helicobacter Pylori Infection and Gastro-Oesophageal Reflux Disease (2006) (0)
Editorial (2001) (0)
Test-and-treat strategy in dyspepsia — the European perspective (2000) (0)
Erratum: The microbiota in inflammatory bowel disease in different age groups (Digestive Diseases (2009) 27 (252-258) DOI: 10.1159/000228558) (2014) (0)
Ösophageale Motiltität bei eosinophiler Ösophagitis (EoE) mitttels high resolution Manometrie (HRM) (2013) (0)
Erratum: The microbiota in inflammatory bowel disease in different age groups (Digestive Diseases (2009) 27 (252-258) DOI: 10.1159/000228558) (2014) (0)
S1930 IBS-Symptoms in Patients with GERD (2009) (0)
Contents Vol. 78, 2008 (2009) (0)
Panel discussion (2004) (0)
Diagnostic and Therapeutic Impact of Double Balloon Enteroscopy in Patients with Crohn’s Disease (2008) (0)
2 Helicobacter pylori Infection Without Histopathological Criteria of Active Gastritis Is Rare but Not Exceptional (2016) (0)
Professional, legal and ethical challenges in gastroenterology. Editorial. (2008) (0)
Repty to the Letter of Krishnamurtliy et al (1995) (0)
Sa1922 – Distinct Shifts in Gut Microbiota Composition Throughout the Gastrointestinal Tract During Healthy Aging (2019) (0)
Whistler Consensus (2007) (0)
The Role of Somatostatin and Octreotide in Pancreatic Disease: Symposium during the EPC Meeting, Ulm, October 1992: Proceedings (1993) (0)
Dynamics in Circulating y -55Proinflammatory Biomarkers for Prognostic Assessment of Patients With Advanced HCC – A Substudy From the SORAMIC Trial (2022) (0)
Gastric precancerous lesions Part 2 Helicobacter pylori infection : A clinical overview Gastric epithelial dysplasia : The Western perspective (2008) (0)
Low-dose aspirin has no impact on systemic level of serine protease inhibitors in healthy volunteers. (2009) (0)
Mo1249 The Presence of Helicobacter pylori Significantly Alters the Pattern of the Active Bacterial Community in Gastric Mucosa- A 16srna- Deep Sequencing Approach (2016) (0)
Mo1578 Gastric Premalignant Gastric Conditions - Changing Trends Over a Period of 15 Years in Germany (2012) (0)
Comprar Chronic Pancreatitis | Albert Singer | 9780632063994 | Wiley (2009) (0)
T1037 Structural Validation of a Quality of Life Questionnaire (FDDQOL) in Patients with Functional Dyspepsia - Reevaluation of a Placebo-Controlled Trial (2008) (0)
Diagnostic in chronic pancreatitis: imaging and function tests (2003) (0)
[Reflux, smoking, alcohol. Approach to prevention of esophageal carcinoma]. (2002) (0)
Influence of colloidal bismuth subcitrate on enzyme secretion from isolated rat pancreatic acinar cells (1992) (0)
Contents Vol. 77, 2008 (2008) (0)
Contents Vol. 21, 2003 (2004) (0)
Do we need alternative treatment options for autoimmune hepatitis? (2006) (0)
Retraction Statement. Paper by Iebba V, Aloi M, Civitelli F, Cucchiara S: Digestive Diseases 2011;29:531-539 (DOI: 10.1159/000332969) (2014) (0)
Frequency of Non-Small Bowel Etiologies of Obscure Gastroinestinal Bleeding in Patients Referred for Double Balloon Enteroscopy (2008) (0)
[Clinical relevance of immunochemical determination of pancreatic lipase in chronic pancreatitis]. (1985) (0)
Helicobacter pylori infection and molecular alterations in gastric carcinogenesis A chance for Prevention (2000) (0)
Title Page / Contents / Imprint / Guidelines (2014) (0)
Retraction Statement. Paper by Iebba V, Aloi M, Civitelli F, Cucchiara S: Digestive Diseases 2011;29:531-539 (DOI: 10.1159/000332969) (2014) (0)
Effect of Single-Shot Antibiotic Treatment on Helicobacter pylori in Patients Undergoing Ulcer Operation (1994) (0)
Clinical Symptom Tool Raises Index of Suspicion for Eosinophilic Oesophagitis in Adults and Drives Earlier Biopsy for Definitive Diagnosis (2017) (0)
Induction of cyclin D3 expression by amphi-regulin in pancreatic cancer (1998) (0)
Front & Back Matter (2014) (0)
Long term efficacy and safety of Tenofovir in patients with severe and progressive acute hepatitis B (2014) (0)
Pancreatic zinc output as a simple marker for evaluating exocrine pancreatic function (1998) (0)
Innovations in Interventional Endoscopy (2009) (0)
Etiology, Pathogenesis, and Diagnosis of Chronic Pancreatitis (2007) (0)
Preface (2014) (0)
Front & Back Matter (2019) (0)
541 Gastric Cancer-Associated MicroRNAs are Differentially Expressed in Preneoplastic Gastric Mucosa (2014) (0)
A prospective and randomised clinical trial of the tyrosine kinase inhibitor imatinib mesylate as an initial therapy of advanced pancreatic cancer. (2004) (0)
H. pylori cagA, vacA and iceA genotype associations with gastroesophageal reflux disease (GERD) compared to other upper gastrointestinal diseases (2000) (0)
Expression of survivin and its correlation with cyclooxygenase-2 in gastric cancer (2001) (0)
[Influence of gastrointestinal factors on adaptation of the pancreas--animal experiment studies]. (1991) (0)
IN-VIVO DETECTION AND DIAGNOSIS OF GASTRIC PRENEOPLASTIC LESIONS BY FOURTH- GENERATION ENDOCYTOSCOPY: A PILOT STUDY (2022) (0)
rophylactic Antibiotic Treatment in Patients With Predicted evere Acute Pancreatitis : A Placebo-Controlled , Double-Blind Trial (2004) (0)
[Helicobacter pylori eradication therapy with bismuth citrate/amoxycillin combination therapy]. (1996) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Peter Malfertheiner?

Peter Malfertheiner is affiliated with the following schools:

Peter Malfertheiner's Academic­Influence.com Rankings

Why Is Peter Malfertheiner Influential?

Peter Malfertheiner's Published Works

Published Works

What Schools Are Affiliated With Peter Malfertheiner?

Peter Malfertheiner's AcademicInfluence.com Rankings